Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech
Coverage 240,393 Raw stories ingested 36,557 rewritten in CS_CZ • 0 to rewrite (last 7 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 30s ago
  • FMP Forex News Fetch every 5 min 1m ago
  • CoinGecko News Fetch every 5 min 1m ago
  • FIO Stock News Fetch every 10 min 3m ago
  • Patria Stock News Fetch every 10 min 3m ago
  • Editorial rewrite Rewrite every minute 30s ago
  • Asset sync Assets every 1 hour 50m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Details Date Content Source Relevance
2026-10-22 15:20 3d ago
2026-10-22 08:45 3d ago
Akcie Cerebras klesly kvůli možné volbě NVIDIA ze strany OpenAI
CBRS Cerebras Systems
FMP Stock News 88
Original source text
Cerebras Systems has shed more than 60% since its splashy debut, yet Wall Street analysts keep raising their price targets. One report about a single customer could determine whether this AI chipmaker stages a massive comeback or slides further into…

Cerebras Systems (NASDAQ:CBRS) currently trades at $117.98. The average analyst price target is $282.55, meaning 139.5% upside.

Cerebras makes wafer-scale AI chips and sells fast cloud inference to CrowdStrike (NASDAQ:CRWD | CRWD Price Prediction) and others; key customers are OpenAI, AWS, CrowdStrike, and G42. The Street-high target goes to UBS analyst Timothy Arcuri at $330.00, meaning about 179.7% upside. That rounds to 180%.

Implied upside above 40% means the market and analysts disagree sharply about this company’s future. The stock has also fallen more than 30%, so the disagreement shows up in real losses for shareholders.

A Hot AI IPO Has Lost Most of Its Debut Value The latest blow involved NVIDIA (NASDAQ:NVDA), via a SemiAnalysis report claiming OpenAI may use NVIDIA GPUs instead of Cerebras hardware for the “Ultrafast” mode of GPT-6.1 Sol. Meanwhile, 19.4 million shares became eligible for trading as post-IPO lock-ups expired. The stock fell 16.61% over the past week and 43.41% over the past month. It has dropped 62.07% from $311.07 at its debut and recently reached a 52-week low of $115.13.

The selloff is specific to Cerebras. Over the same month, the S&P 500 moved -0.04%.

Fundamentals had already started the slide. Second-quarter GAAP revenue of $180.11 million missed the $193.55 million consensus. GAAP EPS of -$2.98 missed the -$0.1801 estimate, mostly because of $377.0 million in stock-based compensation. Management guided third-quarter core gross margin to 38% to 40% and said it expects that to be the low point.

Analysts Still Point to a $25.4 Billion Backlog The bullish argument begins with $25.4 billion in remaining performance obligations. That figure excludes any AWS or other hyperscaler business. Management plans to “more than triple our core revenues in ’27”. Core revenue already rose 103% to $209.87 million last quarter. The CEO said, “Looking forward, we see unbound demand for fast inference.”

UBS makes its thesis on three points: the wafer-scale engine’s speed advantage over GPU clusters, contract backlog visibility, and hyperscalers diversifying away from GPU supply bottlenecks.

Several catalysts are scheduled. The disaggregated inference product with Advanced Micro Devices (NASDAQ:AMD) is due to deploy in Q4. AWS Bedrock availability follows in Q1 2027, and revenue from other hyperscalers should start in mid-2027. Management is aiming core gross margin of 60% plus over time.

Analyst view remains firmly positive. Three analysts rate it Strong Buy, seven rate it Buy, one rates it Hold, and none rate it Sell. The 2027 EPS estimate rose to $1.2737 from $0.9613 60 days ago. That came from nine upward revisions and no cuts. Those revisions show no reaction yet to the OpenAI report. Treat the targets as one data point among many.

Cerebras Fell Hardest While NVIDIA and AMD Slipped The rest of the group fell far less than Cerebras.

NVIDIA slipped 3.01% over the past month but is up 19.02% this year. At $221.97, it sits below a $328.72 aiming, which meaning 48.1% upside. It has 10 Strong Buys, 49 Buys, two Holds, and one Sell. That upside is far smaller than Cerebras’, and NVIDIA is also the reported alternative for the OpenAI work.

AMD fell 11.39% over the past month but remains up 158.09% this year. At $552.72 against a $636.21 aiming, implied upside is 15.1%. It has five Strong Buys, 40 Buys, and 11 Holds.

Cerebras has by far the largest analyst-implied upside in the group. That gap reveals how much execution risk investors see in the smaller company.

A 62% Slide Against a Rising S&P 500 At $117.98, Cerebras trades well below the $282.55 consensus of 11 analysts, meaning 139.5% upside. Shares are down 62.07% since the debut. The S&P 500 has gained 13.37% year to date.

The balance sheet gives the company room to wait. Cash and equivalents total $6.74 billion, and the $850 million revolver remains undrawn. Analysts expect revenue to rise from $887 million this year to $2.95 billion in 2027.

OpenAI Is the Swing Factor for This Rebound The recovery case strengthens if the third-quarter report meets the $214 million to $216 million core revenue guidance and OpenAI confirms its 750 MW, $20 billion-plus commitment. The case weakens if OpenAI switches high-speed inference to NVIDIA. The backlog depends heavily on one customer, and stock-based compensation keeps GAAP losses deep.

I am cautiously bullish. The backlog, cash position, and rising estimates support a recovery. Still, I would want management to address the OpenAI report directly before believing the Street’s targets.

Contact [email protected] for any questions or corrections.
2026-10-22 15:20 3d ago
2026-10-22 08:28 3d ago
Arcataur investovala 512 000 USD do Space Exploration Technologies Corp.
SPCX SpaceX
FMP Stock News 88
Original source text
Arcataur Capital Management LLC purchased a new position in shares of SpaceX (NASDAQ:SPCX – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,396 shares of the company’s stock, valued at approximately $512,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SPCX. Syntax Research Inc. acquired a new position in SpaceX in the second quarter valued at $26,000. Atwood & Palmer Inc. purchased a new position in shares of SpaceX during the second quarter worth about $29,000. PayPay Securities Corp purchased a new stake in SpaceX in the second quarter valued at approximately $30,000. Hickory Point Bank & Trust acquired a new stake in shares of SpaceX in the third quarter valued at approximately $30,000. Finally, Maryland Capital Advisors Inc. acquired a new stake in shares of SpaceX in the third quarter valued at approximately $30,000.

SpaceX Trading Up 7.8% NASDAQ SPCX opened at $159.31 on Thursday. The firm has a market cap of $2.10 trillion and a PE ratio of -1,770.11. The stock’s 50 day simple moving average is $149.18. SpaceX has a 12-month low of $104.83 and a 12-month high of $225.64. The company has a debt-to-equity ratio of 0.29, a current ratio of 5.12 and a quick ratio of 4.99.

SpaceX (NASDAQ:SPCX – Get Free Report) last posted its quarterly earnings results on Tuesday, October 20th. The company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.10 by $0.25. The business had revenue of $14.57 billion during the quarter. During the same period in the prior year, the company earned ($0.36) earnings per share. SpaceX’s revenue for the quarter was up 161.4% on a year-over-year basis. Equities analysts forecast that SpaceX will post 0.07 earnings per share for the current fiscal year. SpaceX News Summary Here are the key news stories impacting SpaceX this week:

Positive Sentiment: Strong Q3 results: SpaceX reported $14.58 billion in revenue, up 161% year over year, and earnings of $0.35 per share versus the $0.10 consensus estimate. Net income reached approximately $4.4 billion, compared with a loss a year earlier. SpaceX quarterly revenue jumps, beats estimates as AI business surges Positive Sentiment: AI business is scaling rapidly: The Super Intelligence segment generated roughly $7.56 billion in revenue, up more than eightfold, and became SpaceX’s largest revenue contributor. Management said new computing deployments are currently producing payback in less than a year, helping validate the company’s AI infrastructure strategy. Why SpaceX Stock Popped After Earnings Positive Sentiment: Upbeat outlook and analyst support: SpaceX guided to $33 billion-$37 billion in first-quarter 2027 revenue, while its backlog reached about $63 billion. JPMorgan raised its price target to $500, and other firms including Wells Fargo, TD Cowen and Needham also increased targets or reiterated bullish ratings. Top Analysts Boost Price Targets After Q3 Beat Positive Sentiment: Merger speculation added momentum: Elon Musk called a Tesla-SpaceX merger a good idea, and both companies formed independent committees to examine a transaction. A combination could create synergies across AI, vehicles, robotics, connectivity and data. However, no deal is certain and shareholder approval would be required. SpaceX and Tesla boards form special committees to review merger Neutral Sentiment: Starlink remains an important financial base: Connectivity revenue rose 69% to approximately $5.25 billion, with 13.6 million consumer subscribers and strong enterprise and government growth. Investors are watching whether subscriber expansion and direct-to-device plans can support the AI buildout. Negative Sentiment: Capital intensity remains the key risk: SpaceX spent about $19.6 billion on capital expenditures in the quarter and expects $35 billion-$40 billion in fourth-quarter spending. Analysts have warned that continued AI expansion could require substantial borrowing and create execution, power-availability and cash-flow risks. SpaceX Bulls Get Louder After Q3 Earnings Print Negative Sentiment: Potential supply and governance overhangs: Upcoming insider share unlocks could increase selling pressure, while concerns about Starlink’s geopolitical exposure and the uncertain terms of any Tesla merger remain risks to valuation. Insiders Place Their Bets In other SpaceX news, COO Gwynne Shotwell sold 342,170 shares of the stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $153.57, for a total value of $52,547,046.90. Following the completion of the transaction, the chief operating officer owned 2,472,035 shares in the company, valued at approximately $379,630,414.95. This represents a 12.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Wall Street Analysts Forecast Growth A number of equities analysts have recently commented on the stock. Phillip Securities raised shares of SpaceX to a “strong sell” rating and set a $75.00 target price on the stock in a report on Friday, July 31st. UBS Group reaffirmed an “overweight” rating and issued a $300.00 target price on shares of SpaceX in a report on Wednesday. Pivotal Research set a $260.00 target price on shares of SpaceX in a report on Wednesday. Wedbush assumed coverage on shares of SpaceX in a research note on Tuesday, June 30th. They set an “outperform” rating and a $190.00 target price for the company. Finally, HSBC reissued a “hold” rating on shares of SpaceX in a report on Wednesday. Three analysts have rated the stock with a Strong Buy rating, thirty have assigned a Buy rating, nine have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $243.08.

Check Out Our Latest Report on SpaceX

SpaceX Company Profile (Free Report)

Space Exploration Technologies Corp., commonly known as SpaceX, is a privately held aerospace company founded in 2002 by Elon Musk. The company develops and operates launch vehicles and spacecraft designed to reduce the cost of access to space and support commercial, government and scientific missions.

SpaceX’s principal products and services include the Falcon 9 and Falcon Heavy rockets, the Dragon spacecraft and the Starlink satellite communications network. Falcon rockets are used to launch satellites, cargo and crew, while Dragon spacecraft support transportation to and from low Earth orbit.

Recommended Stories Five stocks we like better than SpaceX GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding SPCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SpaceX (NASDAQ:SPCX – Free Report).

Receive News & Ratings for SpaceX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SpaceX and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:20 3d ago
2026-10-22 11:01 3d ago
CNX Resources očekává růst zisku při poklesu tržeb
CNX CNX Resources
FMP Stock News 82
Original source text
Wall Street expects a year-over-year increase in earnings on lower revenues when CNX Resources Corporation. (CNX - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 29. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.66 per share in its upcoming report, which represents a year-over-year change of +34.7%.

Revenues are expected to be $400 million, down 5.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 8.39% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for CNX Resources?For CNX Resources, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -3.96%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination makes it difficult to conclusively predict that CNX Resources will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that CNX Resources would post earnings of $0.57 per share when it actually produced earnings of $0.72, delivering a surprise of +26.32%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

CNX Resources doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerEQT Corporation (EQT - Free Report) , another stock in the Zacks Oil and Gas - Exploration and Production - United States industry, is expected to report earnings per share of $0.38 for the quarter ended September 2026. This estimate points to a year-over-year change of -26.9%. Revenues for the quarter are expected to be $1.75 billion, down 0.1% from the year-ago quarter.

The consensus EPS estimate for EQT has been revised 2.2% lower over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -0.08%.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that EQT will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-10-22 15:20 3d ago
2026-10-22 11:01 3d ago
Laureate Education očekává 92% růst čtvrtletního zisku na akcii
LAUR Laureate Education
FMP Stock News 85
Original source text
Laureate Education (LAUR - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on October 29, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis for-profit higher education purveyor is expected to post quarterly earnings of $0.48 per share in its upcoming report, which represents a year-over-year change of +92%.

Revenues are expected to be $477.83 million, up 19.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Laureate Education?For Laureate Education, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +4.17%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination indicates that Laureate Education will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Laureate Education would post earnings of $0.96 per share when it actually produced earnings of $1.00, delivering a surprise of +4.17%.

Over the last four quarters, the company has beaten consensus EPS estimates just once.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Laureate Education appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-10-22 15:19 3d ago
2026-10-22 09:30 3d ago
Tesla ve třetím čtvrtletí překonala odhad upraveného EPS
TSLA Tesla
FMP Stock News 85
Original source text
SummaryTesla faces margin pressure in both automotive and energy segments as CapEx accelerates for FSD, robotaxi, and AI initiatives.Q3'26 deliveries stabilized but failed to show meaningful YoY growth, despite new model launches and discounting.FSD subscription growth has limited revenue impact, and aggressive marketing has eroded brand trust, hindering sales momentum.Negative free cash flow, rising stock-based compensation, and unclear backlog figures highlight financial and operational challenges ahead. sreeyashlohiya/iStock Editorial via Getty Images

Investment Thesis This is my first Buy rating for Tesla, Inc. (TSLA), ever. So bear with me.

Q3 '26 results were mixed. The company beat adjusted EPS expectations (EPS: $0.48/share vs. $0.45 consensus) and missed on

7.94K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-10-22 15:19 3d ago
2026-10-22 10:33 3d ago
Musk očekává dominanci Tesly v osobní dopravě
TSLA Tesla
FMP Stock News 84
Original source text
Elon Musk just claimed Tesla will capture a majority of every passenger mile traveled on Earth, but the gap between that vision and the company's current footprint raises serious questions about what a $1.53 trillion valuation actually prices in.

An analyst on Tesla’s (NASDAQ:TSLA | TSLA Price Prediction) third-quarter call on October 21, 2026, said the company appears to be “pricing lower than competitor Rideshare and other Robotaxi players in most markets.” Chief executive Elon Musk replied that Tesla will “end up doing a majority of all passenger miles on Earth in any country where it is allowed to operate freely.”

He gave no timeline, though he added a caveat: “unless we are stopped by governments, which is certainly a possibility.” He also said he was confident in the prediction and invited people to check it later.

Tesla closed the regular session at $386.47, up 3.41%. By 7:59 PM ET, it had dropped to $373.65 in after-hours trading, down 3.32%. With the company valued at $1.53 trillion, the question for shareholders is how much of this vision the price already includes.

Nearly Two Million Miles Against Billions of Trips
Tesla’s robotaxi fleet has driven nearly two million cumulative unsupervised miles. That total grew eightfold during the quarter, and the service runs in Austin from 6 a.m. to midnight.

Global passenger miles include private cars, taxis, buses, and trains. Uber (NYSE:UBER) alone handled 3.9 billion trips in its second quarter, so Tesla’s entire unsupervised history is a small fraction of one competitor’s three months of activity.

Ashok Elluswamy, who leads AI at Tesla, said the company sees “a clear path towards scaling to millions of vehicles for the next several months.” A forecast about vehicle counts does not prove anything about miles driven, and the call gave no market-share target.

Tesla’s Cost Case Rests on a Goal It Has Not Hit
Management argued that a rideshare car has a driver, “and we don’t.” Tesla also builds its own cars, and Musk said the aim is “to take over any kind of transportation.”

CFO Vaibhav Taneja said Tesla has not yet reached its $0.30 per-mile goal for paid robotaxi miles, though he sees a path to it. The call did not say whether that number is a cost, a price, or a margin, so you cannot yet compare it with ride-hailing economics.

Why “Allowed to Operate Freely” Matters Most
Musk named the biggest risk himself, because a robotaxi needs city and state permits and approval from federal safety regulators at home. Abroad, it needs sign-off country by country, and some governments will protect their domestic automakers.

Elluswamy said the remaining obstacles could become regulatory “perhaps in Q1, Q2 timeframes.” Because the prediction applies only where Tesla can operate “freely,” much of the world may fall outside it.

Ride-Hailing Stocks Fell Before Musk Spoke
Uber slipped 1.91% to $67.62, and Lyft (NASDAQ:LYFT) fell 2.67% to $16.79. Both moves happened during the regular session, before the call. Uber was unchanged after hours.

Uber trades close to its 52-week low of $65.41, well below its high of $100.35. The stock is down 27.31% over the past year and 17.24% year to date.

Uber is approaching autonomy through partners, including Waymo, Wayve, Baidu (NASDAQ:BIDU) and Pony.ai (NASDAQ:PONY), and has committed $10 billion over several years. Driverless rides still make up less than 0.5% of the about 300 million trips Uber handles each week. Uber and Lyft both report soon, and those results will show whether rider demand is holding up.

What Tesla’s Valuation Means for Investors Now
At this price, Tesla’s valuation looks stretched. The stock trades at about 402 times earnings, which assumes a far bigger robotaxi business than one with nearly two million miles. Meanwhile, operating income fell 55.79% as research spending rose to $2.76 billion.

Uber’s valuation is far more modest. It trades at about 14 times earnings and has guided third-quarter non-GAAP EPS of $0.84-$0.88. Because its model works with many partners, it can make money from autonomy no matter whose technology wins.

This view would change if Tesla reported unsupervised miles across several cities that far exceed two million. It would also change if Uber’s next report showed trip growth stalling. Until either happens, watch whether Uber stays above $65.41.

Contact [email protected] for any questions or corrections.
2026-10-22 15:19 3d ago
2026-10-22 10:15 3d ago
Analytici očekávají vyšší čtvrtletní zisk na akcii společnosti Coca-Cola
KO Coca-Cola
FMP Stock News 85
Original source text
Analysts on Wall Street project that Coca-Cola (KO - Free Report) will announce quarterly earnings of $0.87 per share in its forthcoming report, representing an increase of 6.1% year over year. Revenues are projected to reach $12.93 billion, increasing 4.1% from the same quarter last year.

The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.

Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.

That said, let's delve into the average estimates of some Coca-Cola metrics that Wall Street analysts commonly model and monitor.

The consensus estimate for 'Net Operating Revenues- North America' stands at $5.47 billion. The estimate points to a change of +4.1% from the year-ago quarter.

The collective assessment of analysts points to an estimated 'Net Operating Revenues- Latin America' of $1.73 billion. The estimate indicates a year-over-year change of +9.7%.

Based on the collective assessment of analysts, 'Net Operating Revenues- Asia Pacific' should arrive at $1.46 billion. The estimate indicates a change of -3.1% from the prior-year quarter.

Analysts forecast 'Net Operating Revenues- Bottling investments' to reach $1.40 billion. The estimate indicates a year-over-year change of +3.7%.

The average prediction of analysts places 'Net Operating Revenues- Europe, Middle East & Africa' at $3.08 billion. The estimate points to a change of +2.8% from the year-ago quarter.

The consensus among analysts is that 'Net Operating Revenues- Corporate' will reach $34.43 million. The estimate suggests a change of +1.3% year over year.

The combined assessment of analysts suggests that 'Operating Income- Europe, Middle East & Africa- Non-GAAP' will likely reach $1.14 billion. The estimate is in contrast to the year-ago figure of $1.08 billion.

Analysts' assessment points toward 'Operating Income- Bottling Investments- Non-GAAP' reaching $72.61 million. The estimate compares to the year-ago value of $58.00 million.

Analysts expect 'Operating income- North America- Non-GAAP' to come in at $1.70 billion. Compared to the present estimate, the company reported $1.64 billion in the same quarter last year.

According to the collective judgment of analysts, 'Operating Income- Asia Pacific- Non-GAAP' should come in at $504.76 million. The estimate is in contrast to the year-ago figure of $504.00 million.

It is projected by analysts that the 'Operating Income- Latin America- Non-GAAP' will reach $1.02 billion. Compared to the present estimate, the company reported $887.00 million in the same quarter last year.

View all Key Company Metrics for Coca-Cola here>>>

Coca-Cola shares have witnessed a change of +5.2% in the past month, in contrast to the Zacks S&P 500 composite's no move. With a Zacks Rank #2 (Buy), KO is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
2026-10-22 15:18 3d ago
2026-10-22 04:59 3d ago
Camarda nakoupila akcie Microsoftu za 1,086 milionu USD
MSFT Microsoft
FMP Stock News 78
Original source text
Camarda Financial Advisors LLC bought a new stake in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 2,911 shares of the software giant’s stock, valued at approximately $1,086,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Dearborn Partners LLC purchased a new stake in shares of Microsoft in the second quarter valued at approximately $75,641,000. Lifetime Wealth Management P.C. acquired a new stake in shares of Microsoft in the second quarter valued at approximately $619,000. Yukon Wealth Management Inc. purchased a new position in Microsoft during the second quarter worth approximately $8,259,000. Brooks Moore & Associates Inc. purchased a new position in Microsoft during the second quarter worth approximately $7,658,000. Finally, Wealth Management Strategies Inc. acquired a new position in Microsoft during the second quarter worth $933,000. Institutional investors and hedge funds own 71.13% of the company’s stock.

Analyst Upgrades and Downgrades Several brokerages have issued reports on MSFT. Yorkville Ives assumed coverage on Microsoft in a report on Monday, October 5th. They issued an “outperform” rating and a $615.00 target price for the company. Raymond James Financial lowered Microsoft from a “moderate buy” rating to a “strong sell” rating in a report on Wednesday, September 23rd. Weiss Ratings upgraded Microsoft from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Royal Bank Of Canada reissued an “outperform” rating on shares of Microsoft in a research report on Thursday, September 10th. Finally, BNP Paribas Exane lowered shares of Microsoft from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Forty-three equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $592.15.

Check Out Our Latest Analysis on MSFT Insider Transactions at Microsoft In related news, CEO Satya Nadella sold 86,525 shares of the stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $501.46, for a total transaction of $43,388,826.50. Following the transaction, the chief executive officer owned 486,763 shares of the company’s stock, valued at approximately $244,092,173.98. This represents a 15.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Takeshi Numoto sold 4,810 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $496.48, for a total value of $2,388,068.80. Following the transaction, the executive vice president owned 42,677 shares of the company’s stock, valued at $21,188,276.96. This trade represents a 10.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 150,314 shares of company stock valued at $75,404,992. Corporate insiders own 0.03% of the company’s stock.

Microsoft Stock Performance Shares of MSFT stock opened at $532.95 on Thursday. The firm’s 50 day moving average price is $507.45 and its 200-day moving average price is $444.58. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.22 and a current ratio of 1.23. Microsoft Corporation has a one year low of $349.20 and a one year high of $553.72. The firm has a market cap of $3.96 trillion, a P/E ratio of 29.67, a P/E/G ratio of 1.71 and a beta of 1.10.

Microsoft (NASDAQ:MSFT – Get Free Report) last posted its earnings results on Wednesday, July 29th. The software giant reported $4.74 earnings per share for the quarter, beating the consensus estimate of $4.24 by $0.50. The firm had revenue of $90.01 billion during the quarter, compared to the consensus estimate of $87.62 billion. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The firm’s revenue for the quarter was up 17.7% on a year-over-year basis. During the same quarter last year, the firm earned $3.65 EPS. As a group, equities research analysts predict that Microsoft Corporation will post 19.65 EPS for the current year.

Microsoft Increases Dividend The company also recently declared a quarterly dividend, which will be paid on Thursday, December 10th. Stockholders of record on Thursday, November 19th will be given a dividend of $0.98 per share. This is an increase from Microsoft’s previous quarterly dividend of $0.91. This represents a $3.92 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Thursday, November 19th. Microsoft’s dividend payout ratio (DPR) is 20.27%.

Microsoft News Roundup Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns Microsoft Profile (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

See Also Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:18 3d ago
2026-10-22 06:12 3d ago
E Wealth Partners koupila 1 462 akcií Microsoftu
MSFT Microsoft
FMP Stock News 85
Original source text
E Wealth Partners LLC acquired a new stake in Microsoft Corporation (NASDAQ:MSFT – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,462 shares of the software giant’s stock, valued at approximately $545,000. Microsoft accounts for about 0.4% of E Wealth Partners LLC’s holdings, making the stock its 13th biggest position.

Several other large investors have also bought and sold shares of the company. Sound Income Strategies LLC raised its holdings in shares of Microsoft by 5.2% in the 2nd quarter. Sound Income Strategies LLC now owns 36,558 shares of the software giant’s stock worth $13,637,000 after purchasing an additional 1,811 shares in the last quarter. First Pacific Financial lifted its stake in Microsoft by 36.4% during the second quarter. First Pacific Financial now owns 28,183 shares of the software giant’s stock valued at $10,513,000 after purchasing an additional 7,527 shares during the last quarter. Hamilton Capital Partners LLC boosted its holdings in Microsoft by 12.3% during the second quarter. Hamilton Capital Partners LLC now owns 57,868 shares of the software giant’s stock worth $21,586,000 after buying an additional 6,339 shares in the last quarter. IFP Advisors Inc boosted its holdings in Microsoft by 3.2% during the second quarter. IFP Advisors Inc now owns 180,462 shares of the software giant’s stock worth $67,316,000 after buying an additional 5,662 shares in the last quarter. Finally, Brindle & Bay Financial Advisors LLC acquired a new position in Microsoft in the second quarter worth approximately $756,000. Institutional investors own 71.13% of the company’s stock.

Wall Street Analyst Weigh In Several research firms have issued reports on MSFT. Yorkville Ives assumed coverage on Microsoft in a report on Monday, October 5th. They issued an “outperform” rating and a $615.00 price target on the stock. Citizens Jmp reissued a “market outperform” rating and set a $550.00 price objective on shares of Microsoft in a research note on Tuesday, September 15th. Cantor Fitzgerald lifted their target price on Microsoft from $522.00 to $608.00 and gave the stock an “overweight” rating in a report on Monday, September 21st. Stifel Nicolaus raised Microsoft from a “hold” rating to a “buy” rating and boosted their target price for the stock from $530.00 to $575.00 in a research report on Tuesday, September 22nd. Finally, Truist Financial reaffirmed a “buy” rating and set a $575.00 target price on shares of Microsoft in a report on Wednesday, July 22nd. Forty-three analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $592.15.

View Our Latest Stock Analysis on MSFT Insiders Place Their Bets In related news, CEO Judson Althoff sold 10,000 shares of the stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total value of $4,878,900.00. Following the completion of the sale, the chief executive officer directly owned 100,447 shares of the company’s stock, valued at approximately $49,007,086.83. This represents a 9.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Takeshi Numoto sold 4,810 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $496.48, for a total value of $2,388,068.80. Following the sale, the executive vice president owned 42,677 shares of the company’s stock, valued at $21,188,276.96. The trade was a 10.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 150,314 shares of company stock worth $75,404,992. 0.03% of the stock is currently owned by corporate insiders.

Microsoft Stock Up 0.2% Shares of NASDAQ:MSFT opened at $532.95 on Thursday. The firm has a 50 day simple moving average of $507.45 and a 200 day simple moving average of $444.58. Microsoft Corporation has a 52 week low of $349.20 and a 52 week high of $553.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.22 and a current ratio of 1.23. The company has a market cap of $3.96 trillion, a PE ratio of 29.67, a price-to-earnings-growth ratio of 1.71 and a beta of 1.10.

Microsoft (NASDAQ:MSFT – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The software giant reported $4.74 earnings per share for the quarter, topping the consensus estimate of $4.24 by $0.50. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The firm had revenue of $90.01 billion for the quarter, compared to analysts’ expectations of $87.62 billion. During the same period in the previous year, the company posted $3.65 EPS. The company’s quarterly revenue was up 17.7% compared to the same quarter last year. As a group, research analysts expect that Microsoft Corporation will post 19.65 earnings per share for the current year.

Microsoft Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 10th. Stockholders of record on Thursday, November 19th will be issued a $0.98 dividend. The ex-dividend date is Thursday, November 19th. This is an increase from Microsoft’s previous quarterly dividend of $0.91. This represents a $3.92 dividend on an annualized basis and a dividend yield of 0.7%. Microsoft’s dividend payout ratio is currently 20.27%.

Key Headlines Impacting Microsoft Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns About Microsoft (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

Featured Articles Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:18 3d ago
2026-10-22 06:12 3d ago
Centaurus koupila 73 120 akcií společnosti Microsoft za přibližně 27 275 000 USD
MSFT Microsoft
FMP Stock News 82
Original source text
Centaurus Financial Inc. acquired a new position in Microsoft Corporation (NASDAQ:MSFT – Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The fund acquired 73,120 shares of the software giant’s stock, valued at approximately $27,275,000. Microsoft makes up 1.1% of Centaurus Financial Inc.’s holdings, making the stock its 20th biggest holding.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Bank of America Corp DE acquired a new stake in Microsoft in the second quarter valued at $27,338,370,000. Legal & General Group Plc bought a new stake in shares of Microsoft in the 2nd quarter worth about $18,306,443,000. Jupiter Topco LLC acquired a new stake in shares of Microsoft in the 2nd quarter valued at about $6,928,664,000. Canada Pension Plan Investment Board bought a new position in shares of Microsoft during the second quarter worth about $5,653,812,000. Finally, The Manufacturers Life Insurance Company bought a new position in shares of Microsoft during the second quarter worth about $4,000,706,000. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

Microsoft Stock Performance Shares of NASDAQ MSFT opened at $532.95 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. The firm’s 50-day moving average price is $507.45 and its two-hundred day moving average price is $444.58. Microsoft Corporation has a 52-week low of $349.20 and a 52-week high of $553.72. The stock has a market capitalization of $3.96 trillion, a P/E ratio of 29.67, a P/E/G ratio of 1.71 and a beta of 1.10.

Microsoft (NASDAQ:MSFT – Get Free Report) last posted its earnings results on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, beating the consensus estimate of $4.24 by $0.50. The company had revenue of $90.01 billion during the quarter, compared to analyst estimates of $87.62 billion. Microsoft had a return on equity of 31.98% and a net margin of 40.31%. The business’s revenue was up 17.7% compared to the same quarter last year. During the same period in the prior year, the company earned $3.65 earnings per share. As a group, sell-side analysts forecast that Microsoft Corporation will post 19.65 earnings per share for the current year. Microsoft Increases Dividend The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 10th. Investors of record on Thursday, November 19th will be paid a dividend of $0.98 per share. This represents a $3.92 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Thursday, November 19th. This is an increase from Microsoft’s previous quarterly dividend of $0.91. Microsoft’s dividend payout ratio (DPR) is currently 20.27%.

Insider Buying and Selling In other Microsoft news, EVP Amy Hood sold 41,674 shares of Microsoft stock in a transaction on Monday, September 14th. The stock was sold at an average price of $498.27, for a total transaction of $20,764,903.98. Following the sale, the executive vice president owned 533,624 shares of the company’s stock, valued at $265,888,830.48. The trade was a 7.24% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Judson Althoff sold 10,000 shares of the company’s stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total transaction of $4,878,900.00. Following the completion of the sale, the chief executive officer directly owned 100,447 shares of the company’s stock, valued at $49,007,086.83. The trade was a 9.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 150,314 shares of company stock valued at $75,404,992 in the last 90 days. Corporate insiders own 0.03% of the company’s stock.

Analysts Set New Price Targets A number of equities analysts recently commented on the company. Argus decreased their price target on Microsoft from $620.00 to $510.00 and set a “buy” rating for the company in a research note on Friday, July 10th. Yorkville Ives initiated coverage on Microsoft in a report on Monday, October 5th. They issued an “outperform” rating and a $615.00 price target for the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $600.00 price target on shares of Microsoft in a research report on Monday, October 12th. Truist Financial reissued a “buy” rating and set a $575.00 price target on shares of Microsoft in a research report on Wednesday, July 22nd. Finally, Rothschild & Co Redburn set a $440.00 price objective on Microsoft in a research note on Monday, September 21st. Forty-three investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Microsoft presently has a consensus rating of “Moderate Buy” and a consensus price target of $592.15.

Check Out Our Latest Analysis on Microsoft

Key Stories Impacting Microsoft Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns About Microsoft (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

Read More Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:18 3d ago
2026-10-22 06:12 3d ago
Coastal Bridge nakoupila akcie Microsoft za 28,24 milionu USD
MSFT Microsoft
FMP Stock News 78
Original source text
Coastal Bridge Advisors LLC purchased a new stake in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 75,705 shares of the software giant’s stock, valued at approximately $28,240,000. Microsoft makes up about 1.7% of Coastal Bridge Advisors LLC’s investment portfolio, making the stock its 12th biggest position.

A number of other hedge funds have also recently made changes to their positions in MSFT. Strategic Wealth Advisors LLC boosted its position in Microsoft by 1.7% during the 2nd quarter. Strategic Wealth Advisors LLC now owns 1,473 shares of the software giant’s stock worth $549,000 after buying an additional 24 shares during the period. Friedenthal Financial grew its holdings in Microsoft by 6.2% during the 1st quarter. Friedenthal Financial now owns 431 shares of the software giant’s stock worth $160,000 after acquiring an additional 25 shares during the last quarter. Sequent Planning LLC increased its position in Microsoft by 0.7% in the 1st quarter. Sequent Planning LLC now owns 3,733 shares of the software giant’s stock valued at $1,382,000 after acquiring an additional 25 shares during the period. Lee Johnson Capital Management LLC increased its position in Microsoft by 3.8% in the 2nd quarter. Lee Johnson Capital Management LLC now owns 687 shares of the software giant’s stock valued at $256,000 after acquiring an additional 25 shares during the period. Finally, Riverpoint Wealth Management Holdings LLC increased its position in Microsoft by 0.5% in the 1st quarter. Riverpoint Wealth Management Holdings LLC now owns 5,543 shares of the software giant’s stock valued at $2,052,000 after acquiring an additional 26 shares during the period. 71.13% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In Several analysts recently weighed in on MSFT shares. Evercore raised shares of Microsoft from an “underperform” rating to an “outperform” rating in a research note on Monday, October 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $600.00 target price on shares of Microsoft in a research report on Monday, October 12th. Melius Research set a $665.00 target price on Microsoft and gave the stock a “buy” rating in a report on Monday, October 5th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Microsoft in a research report on Thursday, September 10th. Finally, Citigroup increased their price target on Microsoft from $600.00 to $636.00 and gave the company a “buy” rating in a research note on Thursday, October 15th. Forty-three investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $592.15.

View Our Latest Stock Report on MSFT Insiders Place Their Bets In other news, EVP Amy Hood sold 41,674 shares of the business’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $498.27, for a total value of $20,764,903.98. Following the transaction, the executive vice president directly owned 533,624 shares of the company’s stock, valued at $265,888,830.48. The trade was a 7.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Judson Althoff sold 10,000 shares of the company’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $487.89, for a total value of $4,878,900.00. Following the sale, the chief executive officer owned 100,447 shares in the company, valued at approximately $49,007,086.83. The trade was a 9.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 150,314 shares of company stock valued at $75,404,992 over the last 90 days. 0.03% of the stock is owned by company insiders.

Microsoft Trading Up 0.2% MSFT opened at $532.95 on Thursday. Microsoft Corporation has a twelve month low of $349.20 and a twelve month high of $553.72. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. The company has a fifty day moving average of $507.45 and a 200-day moving average of $444.58. The stock has a market cap of $3.96 trillion, a PE ratio of 29.67, a price-to-earnings-growth ratio of 1.71 and a beta of 1.10.

Microsoft (NASDAQ:MSFT – Get Free Report) last announced its earnings results on Wednesday, July 29th. The software giant reported $4.74 earnings per share for the quarter, topping analysts’ consensus estimates of $4.24 by $0.50. The business had revenue of $90.01 billion during the quarter, compared to the consensus estimate of $87.62 billion. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. Microsoft’s quarterly revenue was up 17.7% on a year-over-year basis. During the same quarter last year, the firm earned $3.65 earnings per share. On average, sell-side analysts predict that Microsoft Corporation will post 19.65 EPS for the current year.

Microsoft Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 10th. Shareholders of record on Thursday, November 19th will be issued a dividend of $0.98 per share. This represents a $3.92 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Thursday, November 19th. This is an increase from Microsoft’s previous quarterly dividend of $0.91. Microsoft’s dividend payout ratio (DPR) is 20.27%.

Key Stories Impacting Microsoft Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns Microsoft Company Profile (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

Featured Articles Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:18 3d ago
2026-10-22 06:12 3d ago
Hayek Kallen nakoupil akcie Microsoftu za 21,844 milionu USD
MSFT Microsoft
FMP Stock News 78
Original source text
Hayek Kallen Investment Management acquired a new position in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 58,559 shares of the software giant’s stock, valued at approximately $21,844,000. Microsoft makes up about 6.6% of Hayek Kallen Investment Management’s portfolio, making the stock its 2nd largest position.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Frankly Finances LLC purchased a new stake in shares of Microsoft in the second quarter worth $35,000. Bard Associates Inc. bought a new stake in shares of Microsoft during the second quarter valued at approximately $37,000. PMV Capital Advisers LLC purchased a new stake in Microsoft during the 2nd quarter valued at $38,000. Fiduciary Advisors Inc. increased its holdings in shares of Microsoft by 37.4% in the 2nd quarter. Fiduciary Advisors Inc. now owns 125 shares of the software giant’s stock worth $47,000 after purchasing an additional 34 shares in the last quarter. Finally, Persistent Asset Partners Ltd bought a new stake in shares of Microsoft in the 2nd quarter worth $60,000. Hedge funds and other institutional investors own 71.13% of the company’s stock.

Wall Street Analyst Weigh In Several equities research analysts recently commented on the company. Oppenheimer increased their price objective on Microsoft from $515.00 to $570.00 and gave the company an “outperform” rating in a research report on Tuesday, September 22nd. Truist Financial restated a “buy” rating and set a $575.00 price objective on shares of Microsoft in a research report on Wednesday, July 22nd. Tigress Financial raised their target price on shares of Microsoft from $680.00 to $690.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Scotiabank lifted their target price on shares of Microsoft from $510.00 to $615.00 and gave the stock an “outperform” rating in a research report on Monday, October 5th. Finally, Bank of America increased their price target on Microsoft from $500.00 to $600.00 and gave the company a “buy” rating in a report on Tuesday, September 1st. Forty-three research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Microsoft presently has a consensus rating of “Moderate Buy” and a consensus target price of $592.15.

Check Out Our Latest Stock Report on MSFT Microsoft Price Performance Shares of NASDAQ:MSFT opened at $532.95 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $3.96 trillion, a PE ratio of 29.67, a price-to-earnings-growth ratio of 1.71 and a beta of 1.10. The firm’s 50 day moving average price is $507.45 and its 200-day moving average price is $444.58. Microsoft Corporation has a twelve month low of $349.20 and a twelve month high of $553.72.

Microsoft (NASDAQ:MSFT – Get Free Report) last announced its earnings results on Wednesday, July 29th. The software giant reported $4.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.24 by $0.50. The company had revenue of $90.01 billion during the quarter, compared to analyst estimates of $87.62 billion. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The firm’s quarterly revenue was up 17.7% compared to the same quarter last year. During the same period in the previous year, the business posted $3.65 earnings per share. Equities research analysts expect that Microsoft Corporation will post 19.65 EPS for the current year.

Microsoft Increases Dividend The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 10th. Stockholders of record on Thursday, November 19th will be paid a $0.98 dividend. This is a positive change from Microsoft’s previous quarterly dividend of $0.91. The ex-dividend date is Thursday, November 19th. This represents a $3.92 annualized dividend and a dividend yield of 0.7%. Microsoft’s dividend payout ratio (DPR) is currently 20.27%.

More Microsoft News Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns Insider Buying and Selling In related news, EVP Takeshi Numoto sold 4,810 shares of Microsoft stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $496.48, for a total transaction of $2,388,068.80. Following the transaction, the executive vice president directly owned 42,677 shares in the company, valued at approximately $21,188,276.96. The trade was a 10.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Satya Nadella sold 86,525 shares of the business’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $501.46, for a total value of $43,388,826.50. Following the sale, the chief executive officer directly owned 486,763 shares of the company’s stock, valued at $244,092,173.98. This represents a 15.09% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 150,314 shares of company stock valued at $75,404,992 in the last 90 days. 0.03% of the stock is owned by company insiders.

Microsoft Company Profile (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

Read More Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:18 3d ago
2026-10-22 06:12 3d ago
Harvey Capital koupila akcie Microsoft Corporation za 17,119 milionu USD
MSFT Microsoft
FMP Stock News 85
Original source text
Harvey Capital Management Inc. bought a new position in Microsoft Corporation (NASDAQ:MSFT – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 45,894 shares of the software giant’s stock, valued at approximately $17,119,000. Microsoft makes up approximately 3.5% of Harvey Capital Management Inc.’s portfolio, making the stock its 5th biggest holding.

Other institutional investors have also recently modified their holdings of the company. N10 Assets LLC bought a new position in shares of Microsoft during the second quarter valued at $6,608,000. Coastal Bridge Advisors LLC bought a new stake in Microsoft in the 2nd quarter worth about $28,240,000. Jefferies Financial Group Inc. bought a new stake in Microsoft in the 2nd quarter worth about $46,868,000. Public Employees Retirement System of Ohio purchased a new position in Microsoft in the 2nd quarter worth about $1,086,787,000. Finally, MASTERINVEST Kapitalanlage GmbH bought a new position in Microsoft during the 2nd quarter valued at about $43,074,000. 71.13% of the stock is owned by hedge funds and other institutional investors.

Microsoft News Roundup Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns Analysts Set New Price Targets Several equities analysts have issued reports on the stock. Phillip Securities cut shares of Microsoft from a “moderate buy” rating to a “hold” rating in a research note on Monday, October 12th. Needham & Company LLC started coverage on Microsoft in a report on Wednesday, September 23rd. They set a “buy” rating on the stock. Yorkville Ives began coverage on Microsoft in a report on Monday, October 5th. They issued an “outperform” rating and a $615.00 target price on the stock. Tigress Financial increased their target price on Microsoft from $680.00 to $690.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Finally, Jefferies Financial Group raised their target price on Microsoft from $575.00 to $650.00 and gave the stock a “buy” rating in a research report on Wednesday, October 14th. Forty-three analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $592.15. Get Our Latest Report on MSFT

Insider Buying and Selling In other news, EVP Amy Hood sold 7,305 shares of the firm’s stock in a transaction dated Tuesday, October 13th. The stock was sold at an average price of $545.42, for a total value of $3,984,293.10. Following the transaction, the executive vice president owned 555,396 shares of the company’s stock, valued at $302,924,086.32. This trade represents a 1.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Judson Althoff sold 10,000 shares of Microsoft stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $487.89, for a total value of $4,878,900.00. Following the transaction, the chief executive officer directly owned 100,447 shares in the company, valued at approximately $49,007,086.83. The trade was a 9.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 150,314 shares of company stock worth $75,404,992. Company insiders own 0.03% of the company’s stock.

Microsoft Trading Up 0.2% Shares of Microsoft stock opened at $532.95 on Thursday. The company’s fifty day simple moving average is $507.45 and its 200-day simple moving average is $444.58. The stock has a market capitalization of $3.96 trillion, a PE ratio of 29.67, a P/E/G ratio of 1.71 and a beta of 1.10. Microsoft Corporation has a 1-year low of $349.20 and a 1-year high of $553.72. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.23 and a quick ratio of 1.22.

Microsoft (NASDAQ:MSFT – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The software giant reported $4.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.24 by $0.50. The firm had revenue of $90.01 billion during the quarter, compared to the consensus estimate of $87.62 billion. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The company’s revenue for the quarter was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.65 EPS. As a group, equities analysts anticipate that Microsoft Corporation will post 19.65 earnings per share for the current year.

Microsoft Increases Dividend The business also recently declared a quarterly dividend, which will be paid on Thursday, December 10th. Shareholders of record on Thursday, November 19th will be issued a dividend of $0.98 per share. This is a boost from Microsoft’s previous quarterly dividend of $0.91. This represents a $3.92 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Thursday, November 19th. Microsoft’s dividend payout ratio is presently 20.27%.

Microsoft Profile (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

Featured Articles Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:18 3d ago
2026-10-22 06:12 3d ago
Dearborn Partners nakoupila akcie společnosti Microsoft za 75,641 milionu USD
MSFT Microsoft
FMP Stock News 72
Original source text
Dearborn Partners LLC acquired a new stake in Microsoft Corporation (NASDAQ:MSFT – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 202,781 shares of the software giant’s stock, valued at approximately $75,641,000. Microsoft accounts for 3.5% of Dearborn Partners LLC’s holdings, making the stock its 2nd biggest holding.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Strategic Wealth Advisors LLC lifted its stake in Microsoft by 1.7% in the second quarter. Strategic Wealth Advisors LLC now owns 1,473 shares of the software giant’s stock valued at $549,000 after acquiring an additional 24 shares during the last quarter. Friedenthal Financial grew its position in shares of Microsoft by 6.2% in the first quarter. Friedenthal Financial now owns 431 shares of the software giant’s stock valued at $160,000 after purchasing an additional 25 shares during the last quarter. Sequent Planning LLC increased its stake in shares of Microsoft by 0.7% in the first quarter. Sequent Planning LLC now owns 3,733 shares of the software giant’s stock worth $1,382,000 after purchasing an additional 25 shares during the period. Lee Johnson Capital Management LLC increased its stake in shares of Microsoft by 3.8% in the second quarter. Lee Johnson Capital Management LLC now owns 687 shares of the software giant’s stock worth $256,000 after purchasing an additional 25 shares during the period. Finally, Riverpoint Wealth Management Holdings LLC boosted its stake in Microsoft by 0.5% during the 1st quarter. Riverpoint Wealth Management Holdings LLC now owns 5,543 shares of the software giant’s stock valued at $2,052,000 after purchasing an additional 26 shares during the period. 71.13% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Microsoft Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns Analyst Ratings Changes A number of research firms have issued reports on MSFT. Piper Sandler reaffirmed an “overweight” rating on shares of Microsoft in a report on Tuesday. Raymond James Financial cut Microsoft from a “moderate buy” rating to a “strong sell” rating in a research report on Wednesday, September 23rd. Sanford C. Bernstein raised their price objective on shares of Microsoft from $660.00 to $662.00 and gave the stock an “outperform” rating in a research note on Monday. CLSA reaffirmed an “outperform” rating on shares of Microsoft in a research report on Thursday, July 30th. Finally, Barclays upped their target price on shares of Microsoft from $512.00 to $600.00 and gave the company an “overweight” rating in a research note on Tuesday, October 13th. Forty-three analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $592.15. Check Out Our Latest Report on Microsoft

Insider Transactions at Microsoft In related news, CEO Judson Althoff sold 10,000 shares of the firm’s stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total value of $4,878,900.00. Following the completion of the transaction, the chief executive officer directly owned 100,447 shares of the company’s stock, valued at $49,007,086.83. This trade represents a 9.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Amy Hood sold 41,674 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $498.27, for a total value of $20,764,903.98. Following the completion of the transaction, the executive vice president directly owned 533,624 shares of the company’s stock, valued at approximately $265,888,830.48. This trade represents a 7.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 150,314 shares of company stock valued at $75,404,992. Company insiders own 0.03% of the company’s stock.

Microsoft Trading Up 0.2% Shares of MSFT opened at $532.95 on Thursday. The stock’s 50-day moving average price is $507.45 and its 200 day moving average price is $444.58. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $3.96 trillion, a price-to-earnings ratio of 29.67, a P/E/G ratio of 1.71 and a beta of 1.10. Microsoft Corporation has a 12-month low of $349.20 and a 12-month high of $553.72.

Microsoft (NASDAQ:MSFT – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, topping analysts’ consensus estimates of $4.24 by $0.50. Microsoft had a return on equity of 31.98% and a net margin of 40.31%. The company had revenue of $90.01 billion during the quarter, compared to the consensus estimate of $87.62 billion. During the same quarter last year, the company earned $3.65 EPS. The company’s quarterly revenue was up 17.7% on a year-over-year basis. As a group, research analysts predict that Microsoft Corporation will post 19.65 earnings per share for the current year.

Microsoft Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, December 10th. Investors of record on Thursday, November 19th will be paid a $0.98 dividend. The ex-dividend date is Thursday, November 19th. This is a positive change from Microsoft’s previous quarterly dividend of $0.91. This represents a $3.92 dividend on an annualized basis and a dividend yield of 0.7%. Microsoft’s dividend payout ratio is currently 20.27%.

Microsoft Company Profile (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

Read More Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:18 3d ago
2026-10-22 06:12 3d ago
Hamilton Capital koupila 12 808 akcií společnosti Microsoft Corporation za 4,778 milionu USD
MSFT Microsoft
FMP Stock News 82
Original source text
Hamilton Capital LLC purchased a new position in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,808 shares of the software giant’s stock, valued at approximately $4,778,000. Microsoft makes up about 0.2% of Hamilton Capital LLC’s investment portfolio, making the stock its 15th largest holding.

Several other hedge funds and other institutional investors have also modified their holdings of MSFT. Bank of America Corp DE purchased a new position in Microsoft during the 2nd quarter valued at about $27,338,370,000. Legal & General Group Plc acquired a new position in Microsoft in the 2nd quarter valued at about $18,306,443,000. Amundi grew its position in Microsoft by 30.8% in the 1st quarter. Amundi now owns 41,675,076 shares of the software giant’s stock valued at $15,426,862,000 after acquiring an additional 9,814,598 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Microsoft by 10.5% during the first quarter. Dimensional Fund Advisors LP now owns 29,323,744 shares of the software giant’s stock worth $10,852,884,000 after purchasing an additional 2,784,809 shares during the period. Finally, Arrowstreet Capital Limited Partnership increased its stake in Microsoft by 64.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 24,264,779 shares of the software giant’s stock worth $8,982,083,000 after purchasing an additional 9,493,778 shares during the period. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity In related news, EVP Amy Hood sold 41,674 shares of the stock in a transaction on Monday, September 14th. The stock was sold at an average price of $498.27, for a total value of $20,764,903.98. Following the transaction, the executive vice president owned 533,624 shares of the company’s stock, valued at $265,888,830.48. This represents a 7.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Takeshi Numoto sold 4,810 shares of the stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $496.48, for a total value of $2,388,068.80. Following the completion of the transaction, the executive vice president directly owned 42,677 shares in the company, valued at $21,188,276.96. This trade represents a 10.13% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 150,314 shares of company stock worth $75,404,992. 0.03% of the stock is currently owned by company insiders.

Analysts Set New Price Targets Several research analysts have recently commented on MSFT shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $600.00 price objective on shares of Microsoft in a research note on Monday, October 12th. KeyCorp restated an “overweight” rating on shares of Microsoft in a report on Thursday, September 3rd. The Goldman Sachs Group reaffirmed a “buy” rating and set a $640.00 target price on shares of Microsoft in a research note on Thursday, July 30th. Cantor Fitzgerald increased their target price on shares of Microsoft from $522.00 to $608.00 and gave the stock an “overweight” rating in a report on Monday, September 21st. Finally, Evercore upgraded shares of Microsoft from an “underperform” rating to an “outperform” rating in a report on Monday, October 5th. Forty-three equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $592.15. Get Our Latest Stock Report on Microsoft

Microsoft Stock Up 0.2% Shares of Microsoft stock opened at $532.95 on Thursday. Microsoft Corporation has a 52-week low of $349.20 and a 52-week high of $553.72. The company has a 50 day moving average of $507.45 and a 200 day moving average of $444.58. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $3.96 trillion, a P/E ratio of 29.67, a P/E/G ratio of 1.71 and a beta of 1.10.

Microsoft (NASDAQ:MSFT – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, beating analysts’ consensus estimates of $4.24 by $0.50. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The company had revenue of $90.01 billion for the quarter, compared to the consensus estimate of $87.62 billion. During the same period in the prior year, the firm posted $3.65 EPS. The company’s quarterly revenue was up 17.7% compared to the same quarter last year. As a group, research analysts forecast that Microsoft Corporation will post 19.65 EPS for the current fiscal year.

Microsoft Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, December 10th. Investors of record on Thursday, November 19th will be paid a dividend of $0.98 per share. The ex-dividend date is Thursday, November 19th. This is an increase from Microsoft’s previous quarterly dividend of $0.91. This represents a $3.92 dividend on an annualized basis and a dividend yield of 0.7%. Microsoft’s payout ratio is presently 20.27%.

Key Stories Impacting Microsoft Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns Microsoft Profile (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

Read More Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:18 3d ago
2026-10-22 06:12 3d ago
Equitable Holdings koupila akcie společnosti Microsoft za 146 milionů USD
MSFT Microsoft
FMP Stock News 82
Original source text
Equitable Holdings Inc. purchased a new stake in Microsoft Corporation (NASDAQ:MSFT – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 392,554 shares of the software giant’s stock, valued at approximately $146,430,000. Microsoft makes up approximately 0.9% of Equitable Holdings Inc.’s investment portfolio, making the stock its 21st biggest holding.

Several other institutional investors have also recently made changes to their positions in MSFT. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in Microsoft by 4.0% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 229,490 shares of the software giant’s stock worth $85,604,000 after purchasing an additional 8,773 shares during the period. D.B. Root & Company LLC bought a new stake in Microsoft in the second quarter valued at approximately $3,652,000. Markel Group Inc. raised its stake in Microsoft by 0.4% in the first quarter. Markel Group Inc. now owns 537,630 shares of the software giant’s stock valued at $199,014,000 after buying an additional 1,950 shares during the period. Bessemer Group Inc. lifted its position in shares of Microsoft by 8.4% in the first quarter. Bessemer Group Inc. now owns 6,921,677 shares of the software giant’s stock valued at $2,562,197,000 after buying an additional 537,634 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. boosted its stake in shares of Microsoft by 138.8% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,356,359 shares of the software giant’s stock worth $502,077,000 after acquiring an additional 788,297 shares during the period. Institutional investors and hedge funds own 71.13% of the company’s stock.

Wall Street Analysts Forecast Growth MSFT has been the topic of a number of recent analyst reports. Cantor Fitzgerald boosted their target price on Microsoft from $522.00 to $608.00 and gave the stock an “overweight” rating in a report on Monday, September 21st. Scotiabank lifted their price objective on shares of Microsoft from $510.00 to $615.00 and gave the stock an “outperform” rating in a research report on Monday, October 5th. Guggenheim reiterated a “buy” rating and issued a $586.00 price objective on shares of Microsoft in a report on Wednesday. Raymond James Financial cut shares of Microsoft from a “moderate buy” rating to a “strong sell” rating in a research note on Wednesday, September 23rd. Finally, Stifel Nicolaus raised shares of Microsoft from a “hold” rating to a “buy” rating and lifted their target price for the stock from $530.00 to $575.00 in a report on Tuesday, September 22nd. Forty-three research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $592.15.

Get Our Latest Report on Microsoft Insider Buying and Selling at Microsoft In other Microsoft news, CEO Satya Nadella sold 86,525 shares of the stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $501.46, for a total transaction of $43,388,826.50. Following the transaction, the chief executive officer owned 486,763 shares in the company, valued at $244,092,173.98. This represents a 15.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Takeshi Numoto sold 4,810 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $496.48, for a total transaction of $2,388,068.80. Following the transaction, the executive vice president directly owned 42,677 shares in the company, valued at $21,188,276.96. This represents a 10.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 150,314 shares of company stock worth $75,404,992. 0.03% of the stock is currently owned by company insiders.

Microsoft Stock Performance Shares of NASDAQ MSFT opened at $532.95 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.23 and a quick ratio of 1.22. The firm has a market cap of $3.96 trillion, a price-to-earnings ratio of 29.67, a P/E/G ratio of 1.71 and a beta of 1.10. The stock’s fifty day moving average price is $507.45 and its two-hundred day moving average price is $444.58. Microsoft Corporation has a one year low of $349.20 and a one year high of $553.72.

Microsoft (NASDAQ:MSFT – Get Free Report) last posted its earnings results on Wednesday, July 29th. The software giant reported $4.74 earnings per share for the quarter, topping analysts’ consensus estimates of $4.24 by $0.50. The company had revenue of $90.01 billion during the quarter, compared to the consensus estimate of $87.62 billion. Microsoft had a return on equity of 31.98% and a net margin of 40.31%. The company’s revenue was up 17.7% on a year-over-year basis. During the same quarter last year, the firm earned $3.65 earnings per share. On average, equities analysts forecast that Microsoft Corporation will post 19.65 EPS for the current year.

Microsoft Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 10th. Shareholders of record on Thursday, November 19th will be paid a $0.98 dividend. This is a positive change from Microsoft’s previous quarterly dividend of $0.91. The ex-dividend date is Thursday, November 19th. This represents a $3.92 annualized dividend and a yield of 0.7%. Microsoft’s dividend payout ratio is presently 20.27%.

Microsoft News Summary Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Expectations are building for another earnings beat, with demand for Azure cloud infrastructure, Microsoft 365 and Copilot supporting revenue and earnings growth. The key catalyst will be Microsoft’s October 28 report, where investors will look for accelerating Azure growth and evidence that AI investments are translating into monetization. Microsoft Earnings Preview Positive Sentiment: Microsoft remains viewed favorably as a relatively cash-generative way to participate in the AI-cloud buildout. While Oracle’s cloud growth is faster, Microsoft’s stronger free cash flow, lower leverage and broad enterprise installed base may provide greater financial resilience as AI capital expenditures rise. Oracle Versus Microsoft Positive Sentiment: A new Boeing fleet-intelligence platform, Dataliner, is being built on Microsoft Azure AI Foundry. The partnership could add a recurring enterprise workload for Azure and demonstrate Microsoft’s ability to embed AI in industry-specific applications. Boeing and Microsoft Dataliner Positive Sentiment: Tavant’s Microsoft Fabric accelerator is now available through Microsoft Marketplace, potentially making it easier for businesses to deploy Fabric-based analytics and AI solutions across Azure. Tavant Fabric Accelerator Neutral Sentiment: GitHub Copilot is reportedly a major customer of Anthropic, highlighting demand for Microsoft’s AI developer tools but also exposing reliance on outside model providers and potential supplier concentration risk. Anthropic Revenue Concentration Negative Sentiment: Microsoft’s withdrawal as anchor tenant from a U.K. AI data-center project because of power-supply delays underscores a growing constraint: electricity and grid access may slow Azure’s AI capacity expansion and increase infrastructure costs. Microsoft Withdraws From UK AI Data Center Project Negative Sentiment: Investors remain concerned that elevated prices for components could make Microsoft’s next-generation Xbox, Project Helix, less competitive or pressure demand. The gaming business is also undergoing restructuring, adding uncertainty beyond Azure and productivity software. Project Helix Pricing Concerns Microsoft Company Profile (Free Report)

Microsoft Corporation (NASDAQ:MSFT) is a global technology company that develops software, cloud services, devices and digital platforms. Its products and services are used by consumers, businesses, governments and educational institutions worldwide.

The company’s principal offerings include the Windows operating system; Microsoft 365 productivity applications such as Word, Excel, Teams and Outlook; Azure cloud computing and infrastructure services; Dynamics business applications; and enterprise security solutions.

Read More Five stocks we like better than Microsoft GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:17 3d ago
2026-10-22 08:45 3d ago
Tržby AMD vzrostly o 50 % na 11,54 mld. USD
AMD AMD
FMP Stock News 90
Original source text
AMD keeps landing hyperscaler deals and posting numbers that silence skeptics, yet the market still prices it like the underdog. Here is why one investor keeps adding shares and what milestones could force Wall Street to finally reassess.

Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) keeps strengthening its case. Every earnings report adds one more data point investors are tracking.

My thesis: AMD sells the main processor inside the server (EPYC CPUs) and the AI chips (Instinct GPUs), and now it ships both together in a full rack called Helios. AMD can hand a hyperscaler the whole system. The customer list shows it: OpenAI is a core partner to use 6 gigawatts of AMD GPUs, Meta Platforms (NASDAQ:META) plans up to 6 gigawatts, and Anthropic plans up to 2 gigawatts.

Three Data Points Driving AMD’s Momentum First, growth remains strong even as the company gets bigger. Q2 FY2026 revenue reached $11.54 billion, up 50.1% year over year. Data Center revenue rose 107% to $6.718 billion and now accounts for 58% of sales. Management guided Q3 revenue to roughly $13 billion, and CEO Lisa Su told investors, “We now expect data center segment revenue to more than double year-over-year in 2027.”

Second, profits are catching up with sales. Non-GAAP operating margin expanded to 27% from 12% a year earlier, and non-GAAP gross margin reached 56%. Free cash flow for full-year 2025 came in at $5.519 billion, up 129.48%. AMD returns capital through buybacks: the company bought back $1.316 billion of stock in FY2025.

Third, the balance sheet gives AMD room to weather rough patches. Debt-to-equity stands at 0.071, net debt to EBITDA is -0.16 (a net cash position), while interest coverage runs 28.2x. Revenue also beat estimates in every quarter from Q2 2024 through Q1 2026, and again in Q2 2026.

Why AMD Stands Out Against NVIDIA and Intel The obvious alternative is NVIDIA (NASDAQ:NVDA), and on trailing earnings it actually looks cheaper at a P/E of 45 versus AMD’s 208. AMD stands apart because of where each company starts. NVIDIA already carries a $5.36 trillion market cap, about 5.9 times AMD’s $902.3 billion. I see more room to compound from the smaller base, especially with AMD’s EPYC franchise riding agentic AI demand for server CPUs.

The cheaper-looking legacy option is Intel (NASDAQ:INTC), but it carries a negative trailing P/E, net debt to EBITDA of 3.40, and interest coverage of -2.03. Its foundry unit posted a $2.1 billion quarterly operating loss, and its Q2 revenue grew 25.4%, well below the pace AMD delivered.

Risks I Watch Most Closely Valuation is the real threat. At a P/E of 208, AMD needs to execute perfectly, and the market punishes stumbles: shares fell 17.31% after the Q4 2025 report despite a 15.98% EPS beat. Supply matters too. Su admitted, “The server CPU supply chain is tight right now.” Export controls also cost AMD about $440 million in FY2025 charges.

Those risks sit against earnings that keep rising toward the multiple. Management now expects revenue growth “substantially above” its prior target of greater than 35% and expects to exceed its $20 annual EPS target within its strategic timeframe. Su added, “We don’t think we see anything that would give us pause about hitting the targets.”

(We reverse-engineered what the biggest tech winners looked like early, from EPYC-style franchise builds to full-rack AI systems, and turned it into a free playbook here: The Next Nvidia Playbook.)

Catalysts Investors Can’t Afford to Miss Into 2027 Helios shipments were scheduled to begin later in the third quarter of 2026, MI500 follows in 2027, and Su says customer pull is “tracking ahead of our initial forecast.” The stock slipped 10.2% over the past month. Su called this “the early stages of a multiyear AI adoption cycle,” and investors should keep an eye on the stock at every stage of it.

Contact [email protected] for any questions or corrections.
2026-10-22 15:16 3d ago
2026-10-22 10:01 3d ago
Nike získal hodnocení Zacks Rank #5 po poklesu odhadu zisku na akcii
NKE Nike
FMP Stock News 72
Original source text
Nike (NKE - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this athletic apparel maker have returned +4.1%, compared to the Zacks S&P 500 composite's no change. During this period, the Zacks Shoes and Retail Apparel industry, which Nike falls in, has gained 4%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Nike is expected to post earnings of $0.36 per share, indicating a change of -32.1% from the year-ago quarter. The Zacks Consensus Estimate has changed -30.8% over the last 30 days.

The consensus earnings estimate of $1.25 for the current fiscal year indicates a year-over-year change of -20.9%. This estimate has changed -27% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $1.56 indicates a change of +24.8% from what Nike is expected to report a year ago. Over the past month, the estimate has changed -31.8%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #5 (Strong Sell) for Nike.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Nike, the consensus sales estimate of $11.22 billion for the current quarter points to a year-over-year change of -9.7%. The $42.75 billion and $43.11 billion estimates for the current and next fiscal years indicate changes of -7.9% and +0.8%, respectively.

Last Reported Results and Surprise HistoryNike reported revenues of $11.21 billion in the last reported quarter, representing a year-over-year change of -4.3%. EPS of $0.48 for the same period compares with $0.49 a year ago.

Compared to the Zacks Consensus Estimate of $11.4 billion, the reported revenues represent a surprise of -1.65%. The EPS surprise was +11.63%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Nike is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Nike. However, its Zacks Rank #5 does suggest that it may underperform the broader market in the near term.
2026-10-22 15:16 3d ago
2026-10-22 05:41 3d ago
Greenland Capital snížila svůj podíl v NVIDIA o 33,1 %
NVDA Nvidia
FMP Stock News 85
Original source text
Greenland Capital Management LP lowered its position in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 33.1% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,672 shares of the computer hardware maker’s stock after selling 6,270 shares during the quarter. Greenland Capital Management LP’s holdings in NVIDIA were worth $2,536,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of NVDA. Longview Financial Advisors Inc. bought a new position in shares of NVIDIA during the 1st quarter valued at about $27,000. Montgomery Financial Services LLC bought a new stake in shares of NVIDIA in the 2nd quarter worth approximately $28,000. Langley Wealth Management LLC acquired a new stake in NVIDIA during the second quarter valued at approximately $34,000. Phillip James Consulting Co. bought a new stake in NVIDIA during the first quarter worth approximately $40,000. Finally, Bard Associates Inc. boosted its holdings in NVIDIA by 8,866.7% during the second quarter. Bard Associates Inc. now owns 269 shares of the computer hardware maker’s stock worth $54,000 after buying an additional 266 shares in the last quarter. 65.27% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: SpaceX demand supported the broader AI trade. Elon Musk said SpaceX is adding approximately 200,000 chips per month, strengthening investor confidence that spending on NVIDIA’s systems remains robust. Nvidia Stock Rises as SpaceX Adds Chips Positive Sentiment: New DSX platforms could accelerate revenue deployment. NVIDIA introduced the factory-built DSX POD, which packages Vera Rubin computing, networking, cabling, power and liquid cooling in modular units. The design could reduce deployment time from roughly six months to as little as 14 days, allowing data-center operators to bring AI capacity online and generate revenue sooner. Nvidia Announces Vera Rubin Racks Positive Sentiment: NVIDIA is expanding beyond GPUs into complete AI factories. Its DSX ecosystem targets power, cooling and infrastructure constraints, with claims of up to 30% lower power use and near-zero cooling-water consumption in some designs. Partners including Dell, HPE, Schneider Electric, Vertiv and major cloud providers are supporting the platform. European Ecosystem Builds AI Factories With NVIDIA DSX Positive Sentiment: Multiple partnerships broaden NVIDIA’s long-term opportunity. GTC announcements covered robotics, autonomous vehicles, telecom AI-RAN, enterprise AI-agent security, healthcare and quantum computing. Separately, Agile Robots plans to produce up to 2,000 humanoid robots using NVIDIA technology, highlighting potential growth beyond data centers. Germany’s Agile Robots Partnership Neutral Sentiment: Investors remain focused on execution and competition. Analysts see continued AI spending, but Google and Amazon are developing alternatives to NVIDIA’s software and accelerators. NVIDIA’s high valuation, reliance on partners and reports of sustained insider selling could also limit upside if growth expectations or deployment timelines disappoint. Wall Street Analyst Weigh In Several research firms have issued reports on NVDA. Sanford C. Bernstein restated a “buy” rating on shares of NVIDIA in a research report on Monday, September 21st. DZ Bank reiterated a “buy” rating on shares of NVIDIA in a research report on Wednesday, August 26th. Needham & Company LLC reiterated a “buy” rating on shares of NVIDIA in a research report on Wednesday. Cantor Fitzgerald reissued an “overweight” rating and set a $350.00 price objective on shares of NVIDIA in a research note on Thursday, October 1st. Finally, Yorkville Ives initiated coverage on NVIDIA in a report on Tuesday, October 6th. They issued an “outperform” rating and a $300.00 target price on the stock. Five analysts have rated the stock with a Strong Buy rating, forty-nine have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $321.47. Get Our Latest Stock Report on NVDA

NVIDIA Stock Performance NVIDIA stock opened at $221.88 on Thursday. The firm’s 50 day simple moving average is $223.13 and its 200-day simple moving average is $212.32. The company has a market cap of $5.35 trillion, a P/E ratio of 28.05, a price-to-earnings-growth ratio of 1.66 and a beta of 2.22. The company has a debt-to-equity ratio of 0.14, a current ratio of 4.59 and a quick ratio of 3.85. NVIDIA Corporation has a fifty-two week low of $164.27 and a fifty-two week high of $243.37.

NVIDIA (NASDAQ:NVDA – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.13. The business had revenue of $96.22 billion for the quarter, compared to analyst estimates of $92.27 billion. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The firm’s revenue was up 105.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.05 earnings per share. As a group, equities research analysts predict that NVIDIA Corporation will post 9.30 EPS for the current year.

NVIDIA Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.5%. The ex-dividend date was Thursday, September 10th. NVIDIA’s payout ratio is presently 12.64%.

NVIDIA announced that its Board of Directors has initiated a stock repurchase program on Monday, September 28th that allows the company to repurchase $150.00 billion in shares. This repurchase authorization allows the computer hardware maker to reacquire up to 2.8% of its stock through open market purchases. Share repurchase programs are often a sign that the company’s board believes its stock is undervalued.

Insider Buying and Selling at NVIDIA In other news, CFO Colette Kress sold 34,918 shares of the firm’s stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $219.05, for a total value of $7,648,787.90. Following the completion of the sale, the chief financial officer owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark A. Stevens sold 622,239 shares of the firm’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the completion of the sale, the director directly owned 2,336,531 shares of the company’s stock, valued at approximately $541,187,310.22. This trade represents a 21.03% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,766,118 shares of company stock valued at $399,450,353 in the last three months. 3.94% of the stock is currently owned by company insiders.

NVIDIA Profile (Free Report)

NVIDIA Corporation (NASDAQ: NVDA) is a technology company that designs graphics processing units (GPUs), accelerated computing platforms, networking products and related software. Its technologies support artificial intelligence, machine learning, scientific computing, data analytics, professional visualization and computer graphics.

The company’s products include GeForce GPUs for gaming and personal computing, data center GPUs and systems for AI and high-performance computing, and networking solutions used to connect and manage large-scale computing infrastructure.

Featured Stories Five stocks we like better than NVIDIA GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:16 3d ago
2026-10-22 05:41 3d ago
NVIDIA schválila zpětný odkup akcií až za 150 mld. USD
NVDA Nvidia
FMP Stock News 75
Original source text
Henrickson Nauta Wealth Advisors Inc. boosted its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 40.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,357 shares of the computer hardware maker’s stock after buying an additional 3,583 shares during the quarter. NVIDIA accounts for about 0.6% of Henrickson Nauta Wealth Advisors Inc.’s holdings, making the stock its 18th biggest holding. Henrickson Nauta Wealth Advisors Inc.’s holdings in NVIDIA were worth $2,472,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also made changes to their positions in NVDA. Bank of America Corp DE increased its holdings in NVIDIA by 2.2% in the 2nd quarter. Bank of America Corp DE now owns 195,366,864 shares of the computer hardware maker’s stock valued at $39,090,956,000 after purchasing an additional 4,165,875 shares during the last quarter. Amundi raised its position in NVIDIA by 10.4% in the first quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock valued at $23,329,141,000 after purchasing an additional 12,575,177 shares during the period. Dimensional Fund Advisors LP raised its position in NVIDIA by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 94,521,253 shares of the computer hardware maker’s stock valued at $16,479,126,000 after purchasing an additional 555,221 shares during the period. Deutsche Bank AG lifted its stake in NVIDIA by 2.3% during the second quarter. Deutsche Bank AG now owns 91,954,159 shares of the computer hardware maker’s stock worth $18,399,108,000 after purchasing an additional 2,045,101 shares in the last quarter. Finally, Jupiter Topco LLC acquired a new position in NVIDIA during the second quarter worth $16,156,076,000. 65.27% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity In related news, CFO Colette Kress sold 34,918 shares of the company’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the sale, the chief financial officer directly owned 765,103 shares in the company, valued at approximately $167,595,812.15. This represents a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy S. Teter sold 30,460 shares of the firm’s stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the sale, the executive vice president directly owned 2,687,660 shares in the company, valued at approximately $598,810,648. This trade represents a 1.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,766,118 shares of company stock worth $399,450,353. 3.94% of the stock is currently owned by company insiders.

More NVIDIA News Here are the key news stories impacting NVIDIA this week: Positive Sentiment: SpaceX demand supported the broader AI trade. Elon Musk said SpaceX is adding approximately 200,000 chips per month, strengthening investor confidence that spending on NVIDIA’s systems remains robust. Nvidia Stock Rises as SpaceX Adds Chips Positive Sentiment: New DSX platforms could accelerate revenue deployment. NVIDIA introduced the factory-built DSX POD, which packages Vera Rubin computing, networking, cabling, power and liquid cooling in modular units. The design could reduce deployment time from roughly six months to as little as 14 days, allowing data-center operators to bring AI capacity online and generate revenue sooner. Nvidia Announces Vera Rubin Racks Positive Sentiment: NVIDIA is expanding beyond GPUs into complete AI factories. Its DSX ecosystem targets power, cooling and infrastructure constraints, with claims of up to 30% lower power use and near-zero cooling-water consumption in some designs. Partners including Dell, HPE, Schneider Electric, Vertiv and major cloud providers are supporting the platform. European Ecosystem Builds AI Factories With NVIDIA DSX Positive Sentiment: Multiple partnerships broaden NVIDIA’s long-term opportunity. GTC announcements covered robotics, autonomous vehicles, telecom AI-RAN, enterprise AI-agent security, healthcare and quantum computing. Separately, Agile Robots plans to produce up to 2,000 humanoid robots using NVIDIA technology, highlighting potential growth beyond data centers. Germany’s Agile Robots Partnership Neutral Sentiment: Investors remain focused on execution and competition. Analysts see continued AI spending, but Google and Amazon are developing alternatives to NVIDIA’s software and accelerators. NVIDIA’s high valuation, reliance on partners and reports of sustained insider selling could also limit upside if growth expectations or deployment timelines disappoint. NVIDIA Stock Performance Shares of NVDA stock opened at $221.88 on Thursday. The firm has a 50 day moving average of $223.13 and a two-hundred day moving average of $212.32. The stock has a market capitalization of $5.35 trillion, a PE ratio of 28.05, a P/E/G ratio of 1.66 and a beta of 2.22. The company has a quick ratio of 3.85, a current ratio of 4.59 and a debt-to-equity ratio of 0.14. NVIDIA Corporation has a 52 week low of $164.27 and a 52 week high of $243.37.

NVIDIA (NASDAQ:NVDA – Get Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.13. The business had revenue of $96.22 billion for the quarter, compared to analyst estimates of $92.27 billion. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%. The company’s revenue was up 105.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.05 earnings per share. On average, research analysts predict that NVIDIA Corporation will post 9.30 EPS for the current fiscal year.

NVIDIA declared that its board has approved a stock repurchase program on Monday, September 28th that permits the company to repurchase $150.00 billion in outstanding shares. This buyback authorization permits the computer hardware maker to purchase up to 2.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

NVIDIA Dividend Announcement The business also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were given a $0.25 dividend. The ex-dividend date of this dividend was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a yield of 0.5%. NVIDIA’s dividend payout ratio (DPR) is currently 12.64%.

Analyst Upgrades and Downgrades NVDA has been the subject of several research analyst reports. JPMorgan Chase & Co. raised their price target on NVIDIA from $280.00 to $320.00 and gave the stock an “overweight” rating in a research report on Thursday, August 27th. Rosenblatt Securities reiterated a “buy” rating and issued a $390.00 price objective on shares of NVIDIA in a report on Tuesday, September 29th. Raymond James Financial set a $515.00 target price on NVIDIA and gave the stock a “strong-buy” rating in a research note on Thursday, August 27th. Evercore set a $465.00 target price on NVIDIA and gave the company an “outperform” rating in a report on Thursday, August 27th. Finally, UBS Group restated a “buy” rating on shares of NVIDIA in a report on Friday, October 9th. Five analysts have rated the stock with a Strong Buy rating, forty-nine have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, NVIDIA has a consensus rating of “Buy” and an average target price of $321.47.

Check Out Our Latest Research Report on NVIDIA

About NVIDIA (Free Report)

NVIDIA Corporation (NASDAQ: NVDA) is a technology company that designs graphics processing units (GPUs), accelerated computing platforms, networking products and related software. Its technologies support artificial intelligence, machine learning, scientific computing, data analytics, professional visualization and computer graphics.

The company’s products include GeForce GPUs for gaming and personal computing, data center GPUs and systems for AI and high-performance computing, and networking solutions used to connect and manage large-scale computing infrastructure.

Read More Five stocks we like better than NVIDIA GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:16 3d ago
2026-10-22 09:12 3d ago
Huang neočekává nadbytečnou nabídku pamětí do roku 2029
NVDA Nvidia
FMP Stock News 90
Original source text
Nvidia CEO Jensen Huang told CNBC Thursday that a surplus of memory supply is unlikely by 2029, despite a sell-off in memory stocks over the past week amid concerns about oversupply and weakening demand.

"One of the things that's really great about memory is that you can always use more of it," Huang told CNBC's Arjun Kharpal in a wide-ranging interview on the sidelines of the company's GTC Berlin conference. He added that HBM, a type of random access memory, or RAM, will be used for years to come.

"We're the first company in the world to put LPDDR memory — what goes into your cell phones — into the world's data centers, and it's enabled us to deliver performance that's twice as energy efficient as anything in the world today, and so we're going to continue to use abundant amounts of them as well," he added.

Memory stocks have taken a battering in the past week after an opinion column published in a prominent South Korean publication on Oct. 15 urged the country's government to brace for a deceleration in the AI boom.

The column cited two experts who said they expect to see a "flood of new supply," which will turn the memory market "into a red ocean" in 2029, per CNBC's translation. "The supercycle could be over, and the industry could enter a downturn," by 2029, they wrote.

watch now

Memory is a core component of Nvidia's chips, and a glut of supply could push prices lower and hit profit margins for the companies that make the product, such as SK Hynix, Samsung, and Micron.

SpaceX and Tesla CEO Elon Musk responded to the article at the time, saying that China "will be making a LOT of RAM in 2028."

The memory selloff was also driven by China's ChangXin Memory Technologies, or CXMT, which announced new design architecture that could lead to greater efficiencies. The announcement added to investor concern that CXMT could take market share from rivals SK Hynix, Samsung, and Micron.

"We're open-minded," Huang said Thursday when asked about whether he plans to partner with CXMT and use its memory product. "We work with Chinese companies; just about the whole world works with Chinese companies in the supply chain somewhere."

"China is incredible at the fundamental infrastructure technology, and no country collectively is better at manufacturing than China, and so we have to take their capabilities very seriously," he added.

U.S. regulation 'accelerated' China's chip advancementsHuang also told CNBC that China's advancements in the semiconductor industry are due to mounting U.S. regulations, which pushed the country to speed up its own chip technology and manufacturing.

The U.S. currently restricts exports of the country's most advanced semiconductors to China, including top-end Nvidia chips. However, some Chinese firms are making use of a loophole to access the product's compute power through data centers in Southeast Asia. Experts say that this has been key to Chinese AI models becoming more capable.

China "definitely accelerated because of all the regulations," he said.

"We've definitely accelerated China's initiatives, its nationalization of semiconductor manufacturing capabilities, and all of the industrial support that has been put into that sector, and so there's no question we've accelerated that," he added.

Huang emphasized that American tech firms are "mighty" and are prepared to take on competition "from anybody."
2026-10-22 15:15 3d ago
2026-10-22 09:00 3d ago
Johnson & Johnson zvýšily tržby, GAAP EPS klesl
JNJ Johnson & Johnson
FMP Stock News 92
Original source text
Johnson and Johnson just posted a quarter where one business charged ahead while another quietly stalled, and which side wins out will determine whether the stock earns its premium valuation over rivals like Merck and AbbVie.

Our 24/7 Wall St. price target for Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is $288.66 over the next 12 months. From the $258.93 close on October 20, that works out to 11.48% upside, and our rating is buy.

Metric
Value

Current Price
$258.93

24/7 Wall St. Price Target
$288.66

Upside/Downside
11.48%

Recommendation
BUY

Confidence Level
90%

Our confidence in this call is high. Right now the growth comes from pharma. Last quarter Innovative Medicine grew 7.9% and MedTech grew 2.5%. Over the next year, I think the stock depends on whether devices can close that gap. If MedTech steadies, our target is likely too low.

A Talc Charge Hid a Solid Third Quarter
Shares dropped 1.3% to $255.99 at midday. They are up 2.97% for the week, down 5.19% over the past month and up 25.69% year to date. The 52-week range is $180.59 to $281.07.

In the quarter reported October 13, sales came in at $25.4 billion. Adjusted EPS was $2.59, while GAAP EPS fell to $0.09. About $7 billion of charges explain the drop: the proposed talc settlement plus costs tied to the Firefly Bio deal and the Cell BioMedicines partnership.

Management cut adjusted EPS guidance to $11.05 to $11.15. Leave out the $0.64 deal impact and EPS growth would be close to 9%.

Why Bulls See More Than $300
Our bull case reaches $302.93, which is 17% upside. Tremfya grew 68%, and management sees it becoming a $10 billion-plus franchise. New data released October 19 showed durable fistula remission in Crohn’s disease.

The oral psoriasis drug ICOTYDE has more than 20,000 patients on therapy. CAPLYTA reached $1 billion in year-to-date sales. J&J is targeting more than $50 billion in oncology sales by 2030.

Wall Street is supportive too: there are 16 Buy or Strong Buy ratings and a consensus target of $279.41.

MedTech Is the Business That Has to Catch Up
Our bear case is $250.82. MedTech sales outside the U.S. rose just 0.1%. Abiomed fell 1.5% and surgery fell 1%. Timothy Schmid, speaking for MedTech, put it plainly: “Simply put, we can do better, and we absolutely will.”

Two more risks add to the pressure. Firefly Bio and Cell BioMedicines are expected to reduce 2027 EPS by $1.36 per share, and Stelara keeps losing sales to biosimilars.

The other side deserves weight. U.S. MedTech grew 4.8% and Shockwave grew 17.2%. MedTech’s adjusted margin improved to 22.9%, and VARIPULSE Pro is still awaiting U.S. approval. Separating the Orthopaedics business should also sharpen the focus on the device units that remain.

J&J Trades at a Premium to Merck and AbbVie

Company
Forward P/E
Quarterly Revenue Growth

Johnson & Johnson
21
5.9%

Merck
15
5.1%

AbbVie
16
10.2%

Merck (NYSE:MRK) is a direct oncology competitor with similar growth. Its forward P/E is 15, which suggests investors are paying extra for J&J’s broader set of drug launches.

AbbVie (NYSE:ABBV) has also had to replace sales from a major immunology drug facing biosimilars. It is growing faster at 10.2% and trades at a lower multiple. Against these two peers, our target looks reasonable but leaves little room for MedTech to disappoint.

Pharma Momentum Supports Our BUY Rating
Our 24/7 Wall St. price target is $288.66, with a buy rating and 90% confidence. What tips the call is that strong launches are outrunning Stelara’s decline.

I’d be a buyer if the December 8 Enterprise Business Review shows a credible plan to fix MedTech. I’d stay on the sidelines if device sales outside the U.S. keep stalling into 2027. On balance, I think the drug pipeline earns J&J its premium.

Year
24/7 Wall St. Price Target

2026
$261.98

2027
$287.67

2028
$314.27

2029
$338.34

2030
$358.63

These projections assume J&J keeps executing on its double-digit growth plan. The biggest swing factors are a faster MedTech recovery on the upside and new litigation costs on the downside.

Contact [email protected] for any questions or corrections.
2026-10-22 15:15 3d ago
2026-10-22 08:45 3d ago
Dividendy zajistily 88 % desetiletého výnosu společnosti Altria
MO Altria Group
FMP Stock News 92
Original source text
Altria spent a decade writing down bad bets, watching cigarette volumes shrink, and losing ground on smoke-free products. Yet investors who stuck around still came out ahead, and the reason has almost nothing to do with the stock price.

A decade ago, Altria (NYSE:MO | MO Price Prediction) was a cigarette maker known for a big dividend. It still is. For anyone who held the stock over those 10 years, the dividend accounts for nearly all of the return.

A Decade Spent Trying to Replace the Cigarette
Altria spent heavily to move beyond smoking, and most of those deals went badly. Its JUUL stake was written down, and its heated tobacco partnership with Philip Morris International (NYSE:PM) was unwound. The NJOY e-vapor acquisition led to $2.2B in non-cash impairments in 2025, and NJOY ACE is not returning to market in 2026.

The core business kept shrinking. Domestic cigarette volumes fell 10.0% in 2025, and Marlboro’s retail share slipped to 39.5% in Q2 2026. Price increases still pushed adjusted EPS to $5.42 in 2025.

The dividend grew the whole time. The quarterly payout rose from $0.61 in late 2016 to $1.11 in September 2026, with at least one increase each calendar year.

Your $1,000 Became $2,312, Mostly From Dividends.
Altria figures include reinvested dividends. S&P 500 figures track the price change of the SPDR S&P 500 ETF (NYSEARCA:SPY).

1-Year Return

Initial Investment: $1,000
Current Value: $1,237.80
Total Return: 23.78%
S&P 500 (same period): $1,151.50 (15.15%)

5-Year Return

Initial Investment: $1,000
Current Value: $2,255.70
Total Return: 125.57%
Annualized Return: 17.67%
S&P 500 (same period): $1,705.90 (70.59%)

10-Year Return

Initial Investment: $1,000
Current Value: $2,312.10
Total Return: 131.21%
Annualized Return: 8.74%
S&P 500 (same period): $3,612.50 (261.25%)

Look at the share price alone and the decade barely moved. The stock closed at $63.70 in October 2016, so without dividends, $1,000 would be worth only $1,159, a 15.9% gain. Reinvested dividends added $1,153, or roughly 88% of the total gain.

Staying in took patience. Counting dividends, shares fell 49% between June 2017 and March 2020. Your entry date mattered a lot. Investors who bought in 2021 more than doubled their money and beat the index, while 10-year holders fell well short of the S&P 500.

Why Altria Still Appeals to Income Investors
Altria fits investors who want a steadily growing income stream and can live with a shrinking core business. It fits less well for investors who need to keep up with the broader market. (Building a portfolio you can live off without ever selling a share is the whole premise of our free dividend ladder guide, here.)

The bull case: The forward dividend is $4.44 a year, 2026 adjusted EPS guidance is $5.61 to $5.72, on! PLUS is now in 120,000 stores, and nicotine pouches make up 59.9% of the oral tobacco category.

The bear case: After a 34.38% gain so far this year, the stock sits at $73.90. That is above the $70 average analyst target and close to the $75.85 52-week high. Illicit vapes and a weak record in smoke-free products are still real risks.

Altria’s case rests on income. Over the past decade, nearly all of Altria’s return came from its dividend checks, and only investors who reinvested them finished well ahead.

Contact [email protected] for any questions or corrections.
2026-10-22 15:15 3d ago
2026-10-22 11:01 3d ago
Altria může překonat čtvrtletní odhady zisku
MO Altria Group
FMP Stock News 78
Original source text
Altria (MO - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 29. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis owner of Philip Morris USA, the nation's largest cigarette maker is expected to post quarterly earnings of $1.51 per share in its upcoming report, which represents a year-over-year change of +4.1%.

Revenues are expected to be $5.3 billion, up 1% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.26% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Altria?For Altria, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.26%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination indicates that Altria will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Altria would post earnings of $1.5 per share when it actually produced earnings of $1.48, delivering a surprise of -1.33%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Altria appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-10-22 15:12 3d ago
2026-10-22 11:01 3d ago
Norwegian Cruise Line očekává pokles EPS i tržeb
NCLH Norwegian Cruise Line
FMP Stock News 78
Original source text
The market expects Norwegian Cruise Line (NCLH - Free Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 29. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis cruise operator is expected to post quarterly earnings of $0.91 per share in its upcoming report, which represents a year-over-year change of -24.2%.

Revenues are expected to be $2.88 billion, down 2% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 7.02% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Norwegian Cruise Line?For Norwegian Cruise Line, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.73%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Norwegian Cruise Line will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Norwegian Cruise Line would post earnings of $0.39 per share when it actually produced earnings of $0.48, delivering a surprise of +23.08%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Norwegian Cruise Line appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerRoyal Caribbean (RCL - Free Report) , another stock in the Zacks Leisure and Recreation Services industry, is expected to report earnings per share of $6.38 for the quarter ended September 2026. This estimate points to a year-over-year change of +11%. Revenues for the quarter are expected to be $5.59 billion, up 8.7% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Royal Caribbean has been revised 0.9% down to the current level. Nevertheless, the company now has an Earnings ESP of +0.13%, reflecting a higher Most Accurate Estimate.

When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that Royal Caribbean will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-10-22 15:12 3d ago
2026-10-22 10:30 3d ago
Tržby Intelu vzrostly nejrychleji za 15 let
INTC Intel
FMP Stock News 85
Original source text
Intel shares have shed nearly 15% in a month even as the company posted its strongest revenue growth in fifteen years, and three catalysts could determine whether that pullback becomes a buying opportunity or a warning sign.

The 24/7 Wall St. price target for Intel (NASDAQ:INTC | INTC Price Prediction) is $117.05 over the next 12 months. That means 26.38% upside from $92.62. Our model rates the stock a buy with 70% confidence, which we read as fairly high conviction.

Metric
Value

Current Price
$92.62

Price Target from 24/7 Wall St.
$117.05

Upside/Downside
26.38%

Recommendation
BUY

Confidence Level
70%

The upside depends on three catalysts: the Intel 18A ramp, accelerating Data Center and AI demand, and a foundry business that can win outside customers. If all three deliver, the recent pullback would sit within a real turnaround.

Intel Gave Back 14% in a Month Despite Record Growth
Intel shares have fallen 8.31% over the past week and 14.43% over the past month. Still, the stock is up 151.84% year to date and stands about 34.7% below its 52-week high of $142.35.

On Monday, JPMorgan Chase (NYSE:JPM), a longtime bear, upgraded Intel to neutral from underweight. Intel’s third-quarter report is expected after the close on October 29.

The last earnings report was strong. Q2 revenue came in at $16.13 billion (+25.4% YoY), ahead of estimates for $14.45 billion, and non-GAAP EPS of $0.42 exceeded the $0.22 consensus. CEO Lip-Bu Tan called it the “strongest revenue growth in more than fifteen years.”

Why Bulls See $129 Within Reach
Catalyst 1: 18A execution. Intel 18A output ran about 25% above target, and the cost of the main Panther Lake chip has dropped roughly 50% year to date.

Catalyst 2: AI data center demand. Data Center and AI revenue grew 59% year-over-year and generated $2.5 billion in operating profit. Chief Financial Officer David Zinsner expects the custom ASIC business to move from about a $2 billion run rate to $4 billion.

Catalyst 3: Foundry customers. The 14A PDK 0.9 was on track for October, and the EMIB-T packaging backlog keeps growing. The bull case puts the stock at $129.15. Wall Street’s consensus target is $117.37.

Foundry Losses Remain the Biggest Risk
Intel Foundry still lost $2.1 billion last quarter, and external foundry revenue was only $293 million. Capital spending for 2026 is set to top $20 billion, and management expects PC demand to go down by low double digits. Analyst ratings lean toward caution, with 32 Hold ratings.

Most of the GAAP loss of $2.16 per share came from a $12.53 billion non-cash charge linked to the CHIPS Act escrow, while operating cash flow reached $7 billion. The bear case puts the stock at $90.82.

Intel Trades at a Premium to AMD and NVIDIA
Advanced Micro Devices (NASDAQ:AMD) competes with Intel directly in server and PC CPUs. It trades at 40x forward earnings, and revenue grew 50.11% last quarter. AMD is growing faster at a lower multiple, which makes Intel’s premium look like a payment for a recovery that hasn’t finished yet.

Intel considers NVIDIA (NASDAQ:NVDA) as both a partner and an investor. Shares trade at 25x forward earnings while revenue grew 105.85%.

Company
Forward P/E
PEG Ratio

Intel
63x
0.501

AMD
40x
0.626

NVIDIA
25x
0.479

On PEG, Intel falls in line with its peers, so the 24/7 Wall St. price target looks reasonable, though it assumes Intel keeps growing earnings quickly.

Execution Momentum Tips the Scale Toward Upside
I’m staying with a $117.05 24/7 Wall St. price target and a buy rating at 70% confidence. What tips the scale for me is Intel’s run of 4 consecutive EPS beats.

I’d grow more constructive if the Q3 report confirms the 18A yield increases and lands a named external foundry customer. I’d turn cautious if foundry losses widen or data center growth stalls. Overall, the setup favors more upside.

Year
Price Target from 24/7 Wall St.

2026
$97.45

2027
$121.65

2028
$139.48

2029
$151.25

2030
$170.46

These projections assume Intel keeps executing its current strategy. A decision on high-volume production for 14A, or a pause in that node, could drive the results well above or below these figures.

Contact [email protected] for any questions or corrections.
2026-10-22 15:12 3d ago
2026-10-22 11:02 3d ago
Intel očekává růst zisku i tržeb
INTC Intel
FMP Stock News 85
Original source text
Intel (INTC - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on October 29, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis world's largest chipmaker is expected to post quarterly earnings of $0.39 per share in its upcoming report, which represents a year-over-year change of +69.6%.

Revenues are expected to be $16.44 billion, up 20.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.42% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Intel?For Intel, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +2.22%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination indicates that Intel will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Intel would post earnings of $0.21 per share when it actually produced earnings of $0.42, delivering a surprise of +100.00%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Intel appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-10-22 15:11 3d ago
2026-10-22 05:34 3d ago
Cantor Fitzgerald zvýšil svůj podíl v IBM o 93,1 %
IBM IBM
FMP Stock News 78
Original source text
Cantor Fitzgerald Investment Advisors L.P. increased its holdings in shares of International Business Machines Corporation (NYSE:IBM – Free Report) by 93.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 80,802 shares of the technology company’s stock after purchasing an additional 38,962 shares during the period. Cantor Fitzgerald Investment Advisors L.P.’s holdings in International Business Machines were worth $17,771,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in shares of International Business Machines in the second quarter valued at approximately $21,586,659,000. State Street Corp increased its position in International Business Machines by 2.7% during the second quarter. State Street Corp now owns 56,045,055 shares of the technology company’s stock worth $15,760,430,000 after acquiring an additional 1,450,562 shares during the period. Bank of America Corp DE increased its position in International Business Machines by 7.0% during the first quarter. Bank of America Corp DE now owns 16,063,653 shares of the technology company’s stock worth $3,893,669,000 after acquiring an additional 1,049,602 shares during the period. Bank of New York Mellon Corp acquired a new position in International Business Machines during the 2nd quarter valued at $2,606,782,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in International Business Machines by 0.7% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,621,512 shares of the technology company’s stock valued at $2,143,245,000 after purchasing an additional 53,388 shares during the period. Institutional investors own 58.96% of the company’s stock.

International Business Machines Price Performance NYSE:IBM opened at $250.67 on Thursday. The company has a 50-day moving average of $232.36 and a 200-day moving average of $243.60. The company has a market capitalization of $236.16 billion, a price-to-earnings ratio of 22.24, a PEG ratio of 2.32 and a beta of 0.73. International Business Machines Corporation has a 52 week low of $199.19 and a 52 week high of $332.46. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.74 and a current ratio of 0.79.

International Business Machines (NYSE:IBM – Get Free Report) last posted its earnings results on Wednesday, October 21st. The technology company reported $2.95 earnings per share for the quarter, beating analysts’ consensus estimates of $2.85 by $0.10. International Business Machines had a net margin of 15.52% and a return on equity of 35.65%. The business had revenue of $17.10 billion for the quarter, compared to analysts’ expectations of $16.82 billion. During the same quarter in the previous year, the firm posted $2.65 earnings per share. The firm’s revenue for the quarter was up 4.7% on a year-over-year basis. As a group, equities research analysts anticipate that International Business Machines Corporation will post 12.34 earnings per share for the current fiscal year. Analysts Set New Price Targets Several analysts have issued reports on the stock. Craig Hallum began coverage on shares of International Business Machines in a research report on Wednesday, August 19th. They issued a “buy” rating on the stock. Citic Securities upped their price objective on shares of International Business Machines from $294.00 to $297.00 and gave the company a “buy” rating in a research report on Wednesday, July 29th. Robert W. Baird assumed coverage on shares of International Business Machines in a research note on Tuesday, July 21st. They issued a “neutral” rating and a $230.00 target price for the company. Morgan Stanley lifted their target price on International Business Machines from $190.00 to $238.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 15th. Finally, Jefferies Financial Group lowered their price target on International Business Machines from $320.00 to $260.00 and set a “buy” rating on the stock in a research note on Tuesday, July 21st. Twenty analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $255.76.

Check Out Our Latest Research Report on IBM

Insiders Place Their Bets In other International Business Machines news, SVP Robert Thomas sold 25,000 shares of International Business Machines stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $230.32, for a total transaction of $5,758,000.00. Following the sale, the senior vice president directly owned 47,800 shares of the company’s stock, valued at approximately $11,009,296. The trade was a 34.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.27% of the company’s stock.

Key Headlines Impacting International Business Machines Here are the key news stories impacting International Business Machines this week:

Positive Sentiment: Q3 results exceeded expectations: IBM reported adjusted earnings of $2.95 per share versus consensus estimates near $2.85-$2.88, while revenue rose approximately 5% year over year to $17.1 billion, ahead of the roughly $16.8 billion forecast. IBM beats on top and bottom lines Positive Sentiment: Software and infrastructure growth accelerated: Software revenue increased 8% to $7.8 billion and Infrastructure revenue rose 4% to $3.7 billion. Management said previously delayed infrastructure deals began closing, supporting the view that the prior-quarter slowdown was temporary. IBM raises annual software revenue outlook Positive Sentiment: Cash-flow outlook improved: IBM generated $3.0 billion in free cash flow during the quarter and expects full-year free cash flow to increase by more than $1 billion from the prior year. The company maintained its 4%-5% full-year constant-currency revenue-growth forecast. IBM third-quarter results Positive Sentiment: CEO Arvind Krishna highlighted momentum in enterprise AI and “Super Intelligence” initiatives, while IBM’s partnerships around open-source AI inference and its quantum-computing strategy add longer-term growth catalysts. Neutral Sentiment: IBM’s GAAP net income rose to $2.19 billion from $1.74 billion a year earlier, and the board declared a quarterly dividend of $1.69 per share. Negative Sentiment: Gross margin was narrower than expected, which could limit the benefit of revenue growth if elevated AI, infrastructure, or implementation costs persist. (Free Report)

International Business Machines Corporation (NYSE:IBM), commonly known as IBM, is a global technology and consulting company that helps organizations modernize their information technology and business operations. Its offerings include hybrid cloud solutions, artificial intelligence software and services, enterprise software, IT infrastructure, cybersecurity, data analytics, and technology consulting.

IBM provides products and services to businesses, governments, and other institutions across industries and regions worldwide.

Further Reading Five stocks we like better than International Business Machines GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for International Business Machines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Business Machines and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:11 3d ago
2026-10-22 09:23 3d ago
IBM potvrdil celoroční výhled růstu tržeb
IBM IBM
FMP Stock News 96
Original source text
International Business Machines Corp (NYSE:IBM) maintained its full-year revenue growth and free cash flow targets after first-quarter software strength helped expand margins and lift cash generation.

Revenue rose 1% year-on-year to $14.5 billion in the three months to March, increasing 2% after adjusting for currency movements.

Software revenue increased 7% to $6.3 billion, or 9% at constant currency, supported by growth in hybrid cloud, automation and data products.

The software division's hybrid cloud revenue rose 12%, while automation grew 14% and data increased 5%, highlighting the strength of IBM's core software operations.

Gross profit margin under generally accepted accounting principles (GAAP) increased 170 basis points to 55.2%, while the adjusted operating margin rose 190 basis points to 56.6%.

Free cash flow, which measures cash available after capital expenditure, increased to $2 billion from $1.9 billion a year earlier, while net cash from operating activities reached $4.4 billion.

IBM maintained its full-year expectation for revenue growth of at least 5% at constant currency and free cash flow of about $13.5 billion.

The group expects second-quarter revenue to range between $16.4 billion and $16.75 billion, with currency movements forecast to provide a tailwind of around one to one-and-a-half percentage points to full-year growth.

Consulting revenue declined 2% to $5.1 billion, although the figure was flat after adjusting for currency movements, while infrastructure revenue fell 6% to $2.9 billion.

Infrastructure weakness reflected a 15% decline in IBM Z revenue, the group's mainframe computing business, while distributed infrastructure revenue fell 5%.

Net income from continuing operations dropped 33% to $1.1 billion, compared with $1.6 billion a year earlier, when a tax benefit boosted the previous period's result.

Diluted earnings per share from continuing operations fell to $1.12 from $1.69, while adjusted operating earnings per share declined 5% to $1.60.

IBM returned $1.5 billion to shareholders through dividends during the quarter and invested $7.1 billion in acquisitions, including the purchase of HashiCorp.

The group ended March with $17.6 billion in cash, restricted cash and marketable securities, while total debt rose to $63.3 billion from the end of 2024.

Despite the earnings, shares of IBM were down around 7.5% in premarket trading on Thursday.
2026-10-22 15:11 3d ago
2026-10-22 10:01 3d ago
Akcie UnitedHealth vzrostly za měsíc o 12,3 %
UNH UnitedHealth Group
FMP Stock News 72
Original source text
UnitedHealth Group (UNH - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Shares of this largest U.S. health insurer have returned +12.3% over the past month versus the Zacks S&P 500 composite's no change. The Zacks Medical - HMOs industry, to which UnitedHealth belongs, has gained 10.3% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, UnitedHealth is expected to post earnings of $2.28 per share, indicating a change of +8.1% from the year-ago quarter. The Zacks Consensus Estimate has changed +7.1% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $20.57 points to a change of +25.8% from the prior year. Over the last 30 days, this estimate has changed +4%.

For the next fiscal year, the consensus earnings estimate of $23.25 indicates a change of +13.1% from what UnitedHealth is expected to report a year ago. Over the past month, the estimate has changed +3.2%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for UnitedHealth.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of UnitedHealth, the consensus sales estimate of $111.99 billion for the current quarter points to a year-over-year change of -1.1%. The $448.1 billion and $461.34 billion estimates for the current and next fiscal years indicate changes of +0.1% and +3%, respectively.

Last Reported Results and Surprise HistoryUnitedHealth reported revenues of $112.69 billion in the last reported quarter, representing a year-over-year change of -0.4%. EPS of $4.69 for the same period compares with $2.92 a year ago.

Compared to the Zacks Consensus Estimate of $111.38 billion, the reported revenues represent a surprise of +1.18%. The EPS surprise was +13.83%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

UnitedHealth is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about UnitedHealth. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
2026-10-22 15:11 3d ago
2026-10-22 07:13 3d ago
Cardinal Capital zvýšila svůj podíl ve společnosti Merck o 3,6 %
MRK.US Merck & Company
FMP Stock News 78
Original source text
Cardinal Capital Management lifted its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 99,742 shares of the company’s stock after acquiring an additional 3,507 shares during the period. Merck & Co., Inc. accounts for about 1.7% of Cardinal Capital Management’s investment portfolio, making the stock its 13th largest position. Cardinal Capital Management’s holdings in Merck & Co., Inc. were worth $14,578,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. Round Rock Advisors LLC increased its position in Merck & Co., Inc. by 0.7% during the second quarter. Round Rock Advisors LLC now owns 9,901 shares of the company’s stock worth $1,272,000 after purchasing an additional 66 shares during the last quarter. Cascade Financial Partners LLC boosted its holdings in shares of Merck & Co., Inc. by 0.5% in the 2nd quarter. Cascade Financial Partners LLC now owns 14,746 shares of the company’s stock valued at $1,895,000 after purchasing an additional 80 shares during the last quarter. Somerset Trust Co boosted its holdings in shares of Merck & Co., Inc. by 0.9% in the 2nd quarter. Somerset Trust Co now owns 8,701 shares of the company’s stock valued at $1,118,000 after purchasing an additional 81 shares during the last quarter. Stonebridge Financial Group LLC grew its stake in shares of Merck & Co., Inc. by 0.9% during the 2nd quarter. Stonebridge Financial Group LLC now owns 8,747 shares of the company’s stock valued at $1,124,000 after buying an additional 81 shares during the period. Finally, Stronghold Wealth Management L.L.C. grew its stake in shares of Merck & Co., Inc. by 2.6% during the 2nd quarter. Stronghold Wealth Management L.L.C. now owns 3,237 shares of the company’s stock valued at $416,000 after buying an additional 82 shares during the period. 76.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes A number of research firms have recently commented on MRK. Zacks Research downgraded Merck & Co., Inc. from a “hold” rating to a “strong sell” rating in a report on Monday. Daiwa Securities Group upgraded Merck & Co., Inc. from a “neutral” rating to an “outperform” rating and set a $143.00 price target for the company in a research note on Wednesday, August 12th. UBS Group raised their price objective on Merck & Co., Inc. from $145.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, August 20th. BMO Capital Markets lifted their price objective on Merck & Co., Inc. from $142.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday, August 20th. Finally, CICC Research started coverage on Merck & Co., Inc. in a research note on Wednesday, June 24th. They issued an “outperform” rating and a $138.00 price objective on the stock. Seventeen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $151.92.

Check Out Our Latest Research Report on Merck & Co., Inc. Merck & Co., Inc. Stock Performance Merck & Co., Inc. stock opened at $149.98 on Thursday. The firm has a market capitalization of $370.02 billion, a PE ratio of 119.98, a price-to-earnings-growth ratio of 6.85 and a beta of 0.21. Merck & Co., Inc. has a one year low of $82.01 and a one year high of $156.92. The stock’s 50 day moving average price is $146.55 and its 200 day moving average price is $129.88. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.10 and a current ratio of 1.32.

Merck & Co., Inc. (NYSE:MRK – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.13. Merck & Co., Inc. had a net margin of 4.77% and a return on equity of 16.73%. The company had revenue of $16.61 billion during the quarter, compared to the consensus estimate of $16.37 billion. During the same quarter last year, the company earned $2.13 earnings per share. Merck & Co., Inc.’s revenue for the quarter was up 5.1% on a year-over-year basis. Merck & Co., Inc. has set its FY 2026 guidance at 2.660-2.760 EPS. As a group, sell-side analysts expect that Merck & Co., Inc. will post 2.66 EPS for the current fiscal year.

Merck & Co., Inc. Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Wednesday, October 7th. Investors of record on Tuesday, September 15th were paid a dividend of $0.85 per share. The ex-dividend date of this dividend was Tuesday, September 15th. This represents a $3.40 annualized dividend and a yield of 2.3%. Merck & Co., Inc.’s payout ratio is 272.00%.

Merck & Co., Inc. News Summary Here are the key news stories impacting Merck & Co., Inc. this week:

Positive Sentiment: The European Commission approved KEYTRUDA plus Padcev as perioperative treatment for adults with resectable muscle-invasive bladder cancer. The expanded indication strengthens Merck’s oncology portfolio, supports additional long-term revenue opportunities and reinforces the commercial value of the two-drug combination. European Commission KEYTRUDA and Padcev approval Positive Sentiment: The latest trading session saw Merck outperform the broader market, reflecting investor interest in its strong oncology franchise and recent product catalysts. Merck outperforms the stock market Neutral Sentiment: Merck’s participation in the growing bioconjugation and cell-culture-media markets provides potential exposure to expanding biopharmaceutical research demand, but the reports offer no specific financial impact or new company guidance. Bioconjugation market report Cell culture media market report Neutral Sentiment: Reports on Merck’s phase 3 melanoma results and ETF selling could influence sentiment, but the available information does not provide enough detail to assess the magnitude or durability of either development. Merck phase 3 melanoma results Negative Sentiment: Zacks Research downgraded Merck from “hold” to “strong sell,” adding selling pressure and highlighting valuation or growth concerns. Negative Sentiment: KEYTRUDA and KEYTRUDA QLEX remain Merck’s primary earnings engine, while U.S. growth is expected to moderate as the drug approaches peak penetration. The looming patent cliff and a legal setback affecting subcutaneous KEYTRUDA sales in several European markets increase concerns about Merck’s ability to replace future lost revenue with newer treatments. Merck KEYTRUDA growth and patent cliff analysis Insider Transactions at Merck & Co., Inc. In other news, EVP Jennifer Zachary sold 80,315 shares of Merck & Co., Inc. stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $133.46, for a total transaction of $10,718,839.90. Following the sale, the executive vice president directly owned 45,509 shares of the company’s stock, valued at approximately $6,073,631.14. The trade was a 63.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Chirfi Guindo sold 15,000 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $131.00, for a total value of $1,965,000.00. Following the completion of the transaction, the executive vice president owned 46,613 shares in the company, valued at approximately $6,106,303. This trade represents a 24.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 228,238 shares of company stock worth $29,977,783 over the last three months. Insiders own 0.17% of the company’s stock.

Merck & Co., Inc. Profile (Free Report)

Merck & Co, Inc is a global healthcare company that develops, manufactures and markets prescription medicines, vaccines and animal-health products. Its pharmaceutical business focuses on oncology, infectious diseases, cardiology, immunology and other areas of significant medical need. The company serves patients, healthcare providers and institutions in markets worldwide.

Merck’s principal products include Keytruda, an immunotherapy used to treat a range of cancers; Gardasil and Gardasil 9, vaccines that help protect against human papillomavirus; and Januvia and Janumet, medicines used to manage type 2 diabetes.

Featured Articles Five stocks we like better than Merck & Co., Inc. GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for Merck & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:08 3d ago
2026-10-22 05:24 3d ago
Axxcess snížila svůj podíl v NextEra Energy o 28 %
NEE NextEra Energy
FMP Stock News 75
Original source text
Axxcess Wealth Management LLC trimmed its position in shares of NextEra Energy, Inc. (NYSE:NEE – Free Report) by 28.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,184 shares of the utilities provider’s stock after selling 29,241 shares during the period. Axxcess Wealth Management LLC’s holdings in NextEra Energy were worth $5,694,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of the company. Legal & General Group Plc purchased a new position in shares of NextEra Energy in the 2nd quarter worth $1,465,987,000. GQG Partners LLC bought a new position in shares of NextEra Energy during the 2nd quarter valued at approximately $651,293,000. Canada Pension Plan Investment Board purchased a new stake in NextEra Energy during the 2nd quarter valued at $389,527,000. Amundi raised its holdings in NextEra Energy by 46.5% during the 2nd quarter. Amundi now owns 13,329,077 shares of the utilities provider’s stock valued at $1,169,839,000 after buying an additional 4,231,814 shares during the period. Finally, Caisse de depot et placement du Quebec purchased a new stake in NextEra Energy during the 2nd quarter valued at $288,886,000. 78.72% of the stock is owned by hedge funds and other institutional investors.

NextEra Energy Trading Down 1.0% Shares of NEE opened at $78.10 on Thursday. NextEra Energy, Inc. has a 1-year low of $74.41 and a 1-year high of $98.75. The company has a 50-day moving average of $80.71 and a 200 day moving average of $86.28. The firm has a market capitalization of $162.92 billion, a price-to-earnings ratio of 20.17, a PEG ratio of 2.43 and a beta of 0.64. The company has a debt-to-equity ratio of 1.45, a current ratio of 0.53 and a quick ratio of 0.44.

NextEra Energy (NYSE:NEE – Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The utilities provider reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.04. NextEra Energy had a net margin of 32.40% and a return on equity of 12.28%. The firm had revenue of $8.09 billion during the quarter, compared to the consensus estimate of $8.47 billion. During the same quarter in the previous year, the firm posted $1.13 earnings per share. The company’s revenue was up 1.6% on a year-over-year basis. On average, research analysts expect that NextEra Energy, Inc. will post 4.03 EPS for the current year. NextEra Energy Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were issued a dividend of $0.6232 per share. This represents a $2.49 annualized dividend and a yield of 3.2%. The ex-dividend date was Friday, August 28th. NextEra Energy’s dividend payout ratio (DPR) is presently 55.96%.

Key Stories Impacting NextEra Energy Here are the key news stories impacting NextEra Energy this week:

Positive Sentiment: Quarterly earnings beat expectations: NextEra reported adjusted EPS of $1.24, up from $1.13 a year earlier and above the $1.20 consensus estimate. Strength at Florida Power & Light (FPL) and growth at NextEra Energy Resources supported the result. NextEra Energy beats third-quarter profit estimates Positive Sentiment: Growth pipeline remains substantial: Energy Resources added 3.7 gigawatts of renewables and storage to its backlog, bringing the total to approximately 36.7 GW. Management also highlighted a roughly $20 billion data-center pipeline and 9.7% EPS growth. NextEra Energy Q3 2026 earnings call transcript Positive Sentiment: 2026 outlook reaffirmed: NextEra maintained its adjusted EPS target of $3.92 to $4.02 and said it is targeting the high end of that range, reducing near-term guidance risk. Sanford C. Bernstein also reaffirmed an Outperform rating with a $108 price target. NextEra Energy tops Q3 earnings estimates Neutral Sentiment: Dominion transaction remains a longer-term catalyst and risk: Shareholders approved the proposed combination, which the companies still expect to close in the second half of 2027. The deal’s eventual benefits depend on regulatory approval and acceptable conditions. NextEra Energy posts third-quarter GAAP net income Negative Sentiment: Revenue missed estimates: Quarterly revenue was $8.09 billion versus the $8.47 billion consensus, despite rising 1.6% year over year. The sales shortfall may temper enthusiasm around the earnings beat. NextEra Energy Q3 earnings beat on FPL strength Negative Sentiment: Merger-related regulatory pressure is increasing: Virginia Governor Abigail Spanberger has urged regulators to reject the Dominion-NextEra deal in its current form and is seeking a six-year rate freeze, greater bill credits and more transparency. These demands could delay the transaction or reduce its financial benefits. Virginia wants six-year rate freeze in NextEra-Dominion deal Analysts Set New Price Targets NEE has been the topic of several recent analyst reports. Barclays set a $84.00 target price on shares of NextEra Energy and gave the company an “equal weight” rating in a research note on Monday. HC Wainwright reaffirmed a “buy” rating on shares of NextEra Energy in a research note on Monday, July 27th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $108.00 price target on shares of NextEra Energy in a research note on Wednesday. Mizuho cut their price target on shares of NextEra Energy from $95.00 to $80.00 and set a “neutral” rating on the stock in a report on Tuesday, October 6th. Finally, Jefferies Financial Group reiterated a “hold” rating on shares of NextEra Energy in a report on Thursday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $98.05.

View Our Latest Report on NextEra Energy

NextEra Energy Profile (Free Report)

NextEra Energy, Inc is an energy infrastructure company headquartered in Juno Beach, Florida. Through its businesses, the company generates, transmits, distributes and sells electricity, with a focus on regulated utility operations and clean energy development.

Florida Power & Light Company, NextEra Energy’s principal regulated utility, serves customers across much of Florida. FPL operates electric generation, transmission and distribution infrastructure and provides retail electricity service to residential, commercial and industrial customers.

NextEra Energy Resources develops, owns and operates renewable energy and energy storage projects, including wind and solar facilities.

Recommended Stories Five stocks we like better than NextEra Energy GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding NEE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NextEra Energy, Inc. (NYSE:NEE – Free Report).

Receive News & Ratings for NextEra Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextEra Energy and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:08 3d ago
2026-10-22 10:15 3d ago
Analytici očekávají růst EPS a tržeb společnosti American Tower
AMT American Tower
FMP Stock News 78
Original source text
Wall Street analysts expect American Tower (AMT - Free Report) to post quarterly earnings of $2.84 per share in its upcoming report, which indicates a year-over-year increase of 2.2%. Revenues are expected to be $2.77 billion, up 2.1% from the year-ago quarter.

The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.

Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.

Given this perspective, it's time to examine the average forecasts of specific American Tower metrics that are routinely monitored and predicted by Wall Street analysts.

The consensus estimate for 'Total operating revenues- Data Centers' stands at $304.54 million. The estimate points to a change of +14.1% from the year-ago quarter.

Analysts predict that the 'Total operating revenues- Services' will reach $65.96 million. The estimate indicates a change of -34.8% from the prior-year quarter.

The consensus among analysts is that 'Total operating revenues- Total Property' will reach $2.70 billion. The estimate indicates a year-over-year change of +3.2%.

Analysts' assessment points toward 'Geographic Revenues- Total International' reaching $1.12 billion. The estimate points to a change of +8.3% from the year-ago quarter.

The collective assessment of analysts points to an estimated 'Geographic Revenues- U.S. & Canada' of $1.28 billion. The estimate suggests a change of -3.2% year over year.

The average prediction of analysts places 'Geographic Revenues- Africa & APAC' at $418.61 million. The estimate indicates a year-over-year change of +12.8%.

Analysts expect 'Geographic Revenues- Latin America' to come in at $443.17 million. The estimate indicates a year-over-year change of +6.3%.

The combined assessment of analysts suggests that 'U.S. & Canada - Ending Balance' will likely reach 41,771 . Compared to the present estimate, the company reported 41,821 in the same quarter last year.

Analysts forecast 'Total - Ending Balance' to reach 148,696 . The estimate is in contrast to the year-ago figure of 148,371 .

According to the collective judgment of analysts, 'Organic Tenant Billings Growth - Total International' should come in at 1.9%. The estimate compares to the year-ago value of 6.9%.

It is projected by analysts that the 'Organic Tenant Billings Growth - U.S. & Canada' will reach 0.4%. Compared to the present estimate, the company reported 3.9% in the same quarter last year.

Based on the collective assessment of analysts, 'International - Ending Balance' should arrive at 107,068 . The estimate compares to the year-ago value of 106,550 .

View all Key Company Metrics for American Tower here>>>

Over the past month, American Tower shares have recorded returns of +4% versus the Zacks S&P 500 composite's no change. Based on its Zacks Rank #2 (Buy), AMT will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
2026-10-22 15:06 3d ago
2026-10-22 10:23 3d ago
Costco zatím rozdělení akcií neplánuje
COST Costco Wholesale
FMP Stock News 92
Original source text
Costco Wholesale (COST +1.27%) last split its stock in January 2000. Just after the 2-for-1 split, the shares sold for about $49.

Now one share costs roughly $994 as of this writing, or about what 20 shares cost back then. Even after a dip, that's only about 9% off the warehouse club's all-time closing high of $1,094.32, hit in May.

Investors have noticed. An analyst asked about a split on an earnings call, shareholders asked at both of the past two annual meetings, and Costco hasn't announced one.

Could a split finally be coming?

Image source: Getty Images.

Costco says its board keeps looking at itThe fullest answer came from CFO Gary Millerchip on the company's earnings call in December 2024. Asked about splits, Millerchip said there wasn't a plan for one then.

He also laid out why a split matters less than before.

"[T]he economic arguments that were true in the past are a little bit less clear because retail investors and employees both have the ability now to buy fractional shares," Millerchip said.

But he also said a lower share price can make the stock seem more affordable for the same investors and employees. And he added the company would keep talking it over with the board.

CEO Ron Vachris has given shareholders a shorter version of that answer since. At the annual meeting in January 2025, he said there was nothing to report on a split. A year later, at the meeting on Jan. 15, 2026, a shareholder asked about both a split and a special dividend.

"I have nothing to report at this time, but I can tell you that it's being reviewed with the board, and we look at it regularly," Vachris said.

I'd read it as a polite no for now. A split didn't come up in Costco's fiscal fourth-quarter call on Sept. 24, and its next annual meeting is on Jan. 21, 2027.

Two retailers that did splitTwo other retailers split their shares recently, and both said they did it mostly for their employees.

Walmart (WMT +1.42%) announced a 3-for-1 split on Jan. 30, 2024, when its stock closed around $166. Back then, over 400,000 of its workers were in its stock purchase plan. O'Reilly Automotive (ORLY +1.66%) followed in March 2025, when its board approved a 15-for-1 split with the shares near $1,300.

Both CEOs even used the same words, describing the aim as letting employees buy "whole shares, rather than fractions."

Costco's chief financial officer, though, took the other side of that point. After all, fractions are easy to get now. Charles Schwab, for instance, lets investors buy fractional shares of most U.S.-listed stocks for as little as $1.

And the share price alone likely doesn't force Costco's hand. It's about six times what Walmart's stock cost when it announced its split, but below where O'Reilly's was.

A split wouldn't make Costco cheaperEven if Costco did split its shares, its valuation would stay the same. With about 443 million shares outstanding, Costco is worth roughly $441 billion at today's price. A 10-for-1 split would just turn that into about 4.4 billion shares at about $99 each.

What drives the stock over time is what a share earns. Costco earned $20.76 per share in fiscal 2026 (ended Aug. 30, 2026), up 14% from the year before. That's faster than fiscal 2025's 10% gain, so earnings growth is accelerating. Shares around $994 put the stock's price-to-earnings ratio at about 48. That means buyers pay about $48 for every $1 Costco earned last fiscal year. And I think a price like that already asks a lot of a company growing earnings at around 14%, and a split wouldn't change it.

COST Costco Wholesale$1,010.97+$12.66 (+1.27%)

NASDAQ · As of 10:50 AM ET 10/22/26

If Costco wants to give shareholders something, the other item in Vachris' answer could do it. Costco's regular quarterly dividend of $1.47 per share works out to a yield of only around 0.6%, so it isn't much of a dividend stock by itself. But Costco has paid five special dividends since 2012, the biggest a $15 per share payout in January 2024 that cost the company around $6.7 billion. It hasn't paid any since.

Is a split next, then? I doubt one is close. Costco's leaders have given the same answer at least three times since December 2024, and the chief financial officer's point on fractional shares goes against the one Walmart and O'Reilly made.

If a split does happen, it changes the price of a share and little else. I'd focus more on the special dividend, the other item on the board's list, because it's the one that gives shareholders cash.
2026-10-22 15:06 3d ago
2026-10-22 11:02 3d ago
First Solar očekává růst zisku na akcii při poklesu tržeb
FSLR First Solar
FMP Stock News 88
Original source text
First Solar (FSLR - Free Report) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on October 29, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis largest U.S. solar company is expected to post quarterly earnings of $4.64 per share in its upcoming report, which represents a year-over-year change of +9.4%.

Revenues are expected to be $1.31 billion, down 17.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.05% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for First Solar?For First Solar, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.97%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that First Solar will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that First Solar would post earnings of $2.74 per share when it actually produced earnings of $3.92, delivering a surprise of +43.07%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

First Solar doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsFirst Solar (FSLR - Free Report) , another stock in the Zacks Solar industry, is expected to report earnings per share of $4.64 for the quarter ended September 2026. This estimate points to a year-over-year change of +9.4%. Revenues for the quarter are expected to be $1.31 billion, down 17.7% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for First Solar has been revised 2% down to the current level. Nevertheless, the company now has an Earnings ESP of -0.97%, reflecting a lower Most Accurate Estimate.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that First Solar will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-10-22 15:06 3d ago
2026-10-22 11:02 3d ago
Gilead Sciences zřejmě překoná odhad EPS za třetí čtvrtletí
GILD Gilead Sciences
FMP Stock News 82
Original source text
Gilead Sciences (GILD - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on October 29, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis HIV and hepatitis C drugmaker is expected to post quarterly earnings of $2.16 per share in its upcoming report, which represents a year-over-year change of -12.6%.

Revenues are expected to be $7.81 billion, up 0.6% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.29% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Gilead?For Gilead, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +2.24%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination indicates that Gilead will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Gilead would post a loss of$7.07 per share when it actually produced a loss of -$6.75, delivering a surprise of +4.53%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Gilead appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-10-22 15:06 3d ago
2026-10-22 05:09 3d ago
Capstone koupila akcie společnosti AbbVie za 987 000 USD
ABBV AbbVie
FMP Stock News 75
Original source text
Capstone Capital Management Ltd bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 3,772 shares of the company’s stock, valued at approximately $987,000.

Several other hedge funds have also bought and sold shares of the company. Range Financial Group LLC raised its stake in AbbVie by 2.4% in the 3rd quarter. Range Financial Group LLC now owns 5,565 shares of the company’s stock valued at $1,456,000 after acquiring an additional 130 shares during the period. Newman Dignan & Sheerar Inc. boosted its position in AbbVie by 57.9% during the third quarter. Newman Dignan & Sheerar Inc. now owns 6,547 shares of the company’s stock worth $1,713,000 after purchasing an additional 2,400 shares during the period. Benchmark Financial Wealth Advisors LLC boosted its position in AbbVie by 11.0% during the third quarter. Benchmark Financial Wealth Advisors LLC now owns 4,309 shares of the company’s stock worth $1,127,000 after purchasing an additional 428 shares during the period. Cushing Capital Partners LLC bought a new position in AbbVie during the third quarter worth $242,000. Finally, Physician Wealth Advisors Inc. increased its holdings in shares of AbbVie by 11.3% in the third quarter. Physician Wealth Advisors Inc. now owns 1,531 shares of the company’s stock valued at $401,000 after purchasing an additional 155 shares during the last quarter. 70.23% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity In other news, EVP Nicholas Donoghoe sold 32,710 shares of the business’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $250.00, for a total value of $8,177,500.00. Following the completion of the sale, the executive vice president owned 74,430 shares of the company’s stock, valued at approximately $18,607,500. The trade was a 30.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.06% of the company’s stock.

AbbVie Trading Down 1.5% NYSE:ABBV opened at $284.63 on Thursday. The stock has a market cap of $502.89 billion, a P/E ratio of 80.41, a PEG ratio of 1.32 and a beta of 0.24. The stock has a 50 day simple moving average of $264.93 and a 200 day simple moving average of $240.92. AbbVie Inc. has a 1-year low of $190.75 and a 1-year high of $291.40. AbbVie (NYSE:ABBV – Get Free Report) last released its quarterly earnings results on Friday, July 31st. The company reported $3.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.61 by $0.04. AbbVie had a negative return on equity of 422.07% and a net margin of 9.80%. The business had revenue of $16.99 billion during the quarter, compared to the consensus estimate of $16.80 billion. During the same period in the previous year, the company posted $2.97 EPS. The firm’s quarterly revenue was up 10.2% on a year-over-year basis. AbbVie has set its Q3 2026 guidance at 3.840-3.880 EPS. As a group, sell-side analysts forecast that AbbVie Inc. will post 13.94 EPS for the current year.

AbbVie Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Thursday, October 15th will be given a $1.73 dividend. This represents a $6.92 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Thursday, October 15th. AbbVie’s payout ratio is presently 195.48%.

AbbVie News Summary Here are the key news stories impacting AbbVie this week:

Positive Sentiment: AbbVie reported encouraging Phase 2a data for ABBV-466, an investigational combination treatment for Crohn’s disease. The therapy reportedly outperformed Skyrizi alone, strengthening the company’s immunology pipeline and helping offset concerns about the eventual loss of exclusivity for Humira. AbbVie’s Crohn’s Combo Topped Skyrizi Alone in a Phase 2a Trial Positive Sentiment: Allergan Aesthetics, AbbVie’s aesthetics business, presented new and long-term evidence for HArmonyCa, JUVÉDERM, SKINVIVE and BOTOX Cosmetic. Continued product adoption and clinical support could aid growth in the aesthetics segment. Allergan Aesthetics Deepens Science Behind Multimodal Approach Positive Sentiment: The company launched a multiyear partnership with McLaren Racing, including the “AbbVie Race to Innovate” patient-advocacy campaign. The agreement is primarily a branding initiative, but it may increase awareness of AbbVie’s immunology franchise. McLaren Racing Announces Partnership With AbbVie Neutral Sentiment: Analyst comparisons continue to highlight AbbVie’s revenue growth, strong free cash flow and dependable dividend increases. However, the stock’s elevated valuation after its rally leaves less room for disappointment. Negative Sentiment: AbbVie halted a Phase 1b combination trial for early-stage liver cancer. Because the study was in an early development stage, the direct financial impact may be limited, but the decision removes a potential pipeline opportunity and likely weighed on sentiment. AbbVie Halts Early-Stage Liver Cancer Combo Trial Analyst Upgrades and Downgrades Several equities analysts have recently weighed in on the stock. Cantor Fitzgerald increased their price objective on shares of AbbVie from $285.00 to $290.00 and gave the company an “overweight” rating in a research report on Thursday, October 8th. Argus raised their target price on shares of AbbVie from $250.00 to $270.00 in a research note on Tuesday, August 4th. Piper Sandler lifted their target price on shares of AbbVie from $298.00 to $303.00 and gave the stock an “overweight” rating in a report on Thursday, August 20th. Rothschild & Co Redburn upped their price target on shares of AbbVie from $284.00 to $285.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $280.00 price target on shares of AbbVie in a research note on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $278.07.

Read Our Latest Stock Analysis on AbbVie

About AbbVie (Free Report)

AbbVie Inc (NYSE: ABBV) is a global biopharmaceutical company that discovers, develops and commercializes medicines and other healthcare products. Its portfolio focuses on immunology, oncology, neuroscience, aesthetics and eye care, serving patients and healthcare providers in markets around the world.

The company’s key products include immunology medicines such as Skyrizi and Rinvoq; neuroscience treatments including Vraylar, Ubrelvy and Qulipta; and oncology products such as Imbruvica and Venclexta.

See Also Five stocks we like better than AbbVie GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Receive News & Ratings for AbbVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:06 3d ago
2026-10-22 09:00 3d ago
Lutikizumab společnosti AbbVie zlepšil ve studii fáze 3 příznaky hnisavé hidradenitidy
ABBV AbbVie
FMP Stock News 95
Original source text
In the Phase 3 INTREPID study, lutikizumab achieved the primary endpoint of Hidradenitis Suppurativa Clinical Response 75 (HiSCR75) at Week 16 compared with placebo1 Lutikizumab met 8 ranked secondary endpoints, including significant improvements in HS-related skin pain at Week 8 and significant reductions in the occurrence of HS flares over the first 16 weeks,1 reflecting outcomes assessed by both patients and physicians Lutikizumab was generally well tolerated, with no new safety concerns identified1 INTREPID provides Phase 3 data supporting the continued investigation of simultaneous inhibition of IL-1α and IL-1β as a potential treatment approach in adults and adolescents with moderate to severe HS1 NORTH CHICAGO, Ill., Oct. 22, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3 INTREPID study evaluating the safety and efficacy of lutikizumab, an investigational dual-variable-domain interleukin (IL) 1α/1β antagonist, in adults and adolescents with moderate to severe hidradenitis suppurativa (HS).
2026-10-22 15:03 3d ago
2026-10-22 04:36 3d ago
BTIG potvrdila doporučení koupit pro Intuitive Surgical
ISRG Intuitive Surgical
FMP Stock News 78
Original source text
Intuitive Surgical (NASDAQ:ISRG – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at BTIG Research in a research note issued on Wednesday, Benzinga reports. They currently have a $454.00 target price on the medical equipment provider’s stock. BTIG Research‘s price objective indicates a potential upside of 4.62% from the stock’s current price.

Other analysts have also issued reports about the stock. Leerink Partners cut their target price on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research note on Friday, July 17th. Oppenheimer reaffirmed an “outperform” rating and set a $500.00 price objective on shares of Intuitive Surgical in a research report on Wednesday. JPMorgan Chase & Co. cut their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a report on Friday, July 17th. Truist Financial cut their target price on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a report on Thursday, July 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. Twenty-five equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $500.13.

Get Our Latest Research Report on ISRG

Intuitive Surgical Stock Performance Shares of ISRG opened at $433.95 on Wednesday. Intuitive Surgical has a one year low of $328.57 and a one year high of $603.88. The stock’s fifty day moving average is $393.50 and its 200-day moving average is $408.89. The firm has a market capitalization of $153.30 billion, a price-to-earnings ratio of 52.18, a price-to-earnings-growth ratio of 3.30 and a beta of 1.46. Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 17.70%. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the previous year, the firm earned $2.40 EPS. Intuitive Surgical’s revenue was up 21.7% on a year-over-year basis. Analysts forecast that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Activity In other Intuitive Surgical news, VP Fredrik Widman sold 1,089 shares of Intuitive Surgical stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the completion of the sale, the vice president owned 1,026 shares of the company’s stock, valued at approximately $384,175.44. The trade was a 51.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total value of $28,303.20. Following the completion of the transaction, the director directly owned 179 shares in the company, valued at $70,364.90. The trade was a 28.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 12,370 shares of company stock worth $4,891,989. 0.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows A number of institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Plato Investment Management Ltd purchased a new position in Intuitive Surgical in the 2nd quarter worth approximately $4,315,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $14,316,000. Hikari Power Ltd bought a new stake in Intuitive Surgical in the second quarter worth $5,619,000. Nykredit A S bought a new position in shares of Intuitive Surgical during the second quarter valued at about $48,464,000. Finally, NewEdge Advisors LLC increased its holdings in shares of Intuitive Surgical by 19.1% in the second quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock worth $20,212,000 after buying an additional 8,142 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical News Summary Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Strong quarterly execution: Q3 revenue increased 21.7% year over year to $3.05 billion, while adjusted EPS of $3.00 exceeded consensus estimates. Worldwide procedures grew approximately 15%, and da Vinci system placements rose to 546 from 427 a year earlier. Intuitive Surgical’s Q3 Earnings Beat Estimates on Strong System Sales Positive Sentiment: International growth and adoption remain attractive: Management highlighted continued global expansion, with Ion procedures increasing about 31% and total procedure volume maintaining double-digit growth. Lower instrument costs and longer instrument life are intended to broaden robotic-surgery adoption over time. Intuitive Surgical Earnings Call Highlights Global Growth Positive Sentiment: Several analysts remain bullish: Piper Sandler maintained its Buy rating, while JPMorgan raised its target to $475 and BofA kept a $470 target. Other firms reiterated positive ratings, supporting the long-term growth thesis. Piper Sandler Keeps Their Buy Rating on Intuitive Surgical Neutral Sentiment: Valuation raises the bar: With a P/E ratio above 50, investors appear to require exceptionally strong growth. Solid results therefore produced a muted reaction because expectations were already elevated. Intuitive Surgical Stock Faces a Q3 Earnings Valuation Reality Check Negative Sentiment: $450 million antitrust settlement charge: The proposed settlement reduced GAAP net income to $523 million, or $1.49 per diluted share, from $704 million a year earlier. Court approval is still required, adding uncertainty. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement Negative Sentiment: Growth outlook and margins concern investors: Intuitive narrowed 2026 da Vinci procedure-growth guidance to 14%–15%, cited slower U.S. momentum, and expects pricing and extended-use initiatives to reduce revenue per procedure by roughly 3%–5%. Intuitive Narrows 2026 Procedure Growth Outlook (Get Free Report)

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

See Also Five stocks we like better than Intuitive Surgical Meta Bounces Back in Q3, But the Bigger Test Comes in 2027 There’s a New Q in Town: Invesco’s ETF Targets International Innovators Boarding Now—GE Aerospace’s Earnings Beat Comes With a Catch AI Spending Is Surging—But Which Stocks Still Win if It Slows Down?

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:01 3d ago
2026-10-22 09:45 3d ago
Tržby společnosti Regeneron vzrostly o 16,6 % díky Dupixentu
REGN Regeneron Pharmaceuticals
FMP Stock News 90
Original source text
SummaryAt the end of October, Regeneron Pharmaceuticals, Inc. will report its results for Q3.As a reminder, REGN's Q2 revenue rose 18.8% quarter-on-quarter and 16.6% YoY to $4.29 billion, primarily due to the strong performance of Dupixent.On October 12, Regeneron reported positive Phase 3 OPTIMA results, demonstrating sustained Pasatru efficacy in reducing new HO lesions and disease flare-ups in people with FOP.Meanwhile, REGN trades at just 13.8x forward non-GAAP P/E, versus the sector median of 19.5x.In this article, I'll explain why Regeneron Pharmaceuticals offers an appealing risk/reward profile. Klaus Vedfelt/DigitalVision via Getty Images

Following my August article, "Regeneron: Why I Still See Upside After The Rally," which focused primarily on the anti-PD-1 mAb Opdivo and the blockbuster, called Dupixent, Regeneron Pharmaceuticals, Inc.'s (

3.65K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ALVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-10-22 15:01 3d ago
2026-10-22 08:30 3d ago
Orchestra BioMed pořádá 12. listopadu den pro výzkumníky
MDT Medtronic
FMP Stock News 72
Original source text
Company leadership, leading cardiologists and trial investigators to discuss unmet patient needs, BACKBEAT and Virtue pivotal trials, and upcoming milestones; in person in New York City and via live webcast  | Source: Orchestra BioMed Holdings, Inc.

NEW HOPE, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced it will host an R&D Day on November 12th, 2026, at 3:00pm ET in New York City. The event will also be available via live webcast.

Orchestra BioMed leadership will be joined by key leading cardiologists to discuss the clinical and treatment burden associated with uncontrolled hypertension in pacemaker-indicated patients and restenosis in coronary stent interventions, as well as the potential for AVIM Therapy and Virtue SAB to address these unmet needs. The program will also highlight key upcoming clinical milestones and explore the commercial potential of AVIM Therapy and Virtue SAB.

R&D Day Agenda

3:00 PM | Opening Remarks
Led by David Hochman, Chairman and Chief Executive Officer

3:10 PM | AVIM Therapy, BACKBEAT Pivotal Trial & Medtronic Strategic Collaboration
Led by David Hochman & Avi Fischer, MD, Senior Vice President, Medical Affairs & Innovation
Physician Speakers:

Vivek Reddy, MD, Executive Chairman of the BACKBEAT Trial Steering Committee, Director of Cardiac Arrhythmia Services, Mount Sinai Hospital and the Mount Sinai Health SystemMarat Fudim, MD, Associate Professor of Cardiology, Advanced Heart Failure, Duke University Medical Center 4:20 PM | Virtue SAB & Virtue Pivotal Trial
Led by Darren Sherman, President & Chief Operating Officer
Physician Speakers:

Dean Kereiakes, MD, Virtue Trial Co-PI, Chairman of The Christ Hospital Heart and Vascular Institute, The Christ Hospital Health NetworkAllen Jeremias, MD, Virtue Trial Co-PI, Director of the Cardiac Catheterization Laboratory at St. Francis Hospital & Heart Center, New York and an Executive Director for Optimizing PCI 5:15 PM | Q&A Closing Remarks
Moderated by David Hochman and Darren Sherman

Registration and Webcast Information

The R&D Day will be held in person in New York City and streamed via live webcast, and available for replay following the event.

In-person attendance: Please register here. Space is limited, and the Company may not be able to accommodate all requests. In-person registrations are subject to written confirmation, and venue and event details will be provided upon confirmation.Live webcast: Please register here to access the live webcast. A replay will be available on the Investors section of Orchestra BioMed’s website following the event. About Orchestra BioMed

Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies. The Company’s two flagship product candidates - Atrioventricular Interval Modulation (AVIM) Therapy and Virtue® Sirolimus AngioInfusion™ Balloon (Virtue SAB) - are currently undergoing pivotal clinical trials for their lead indications, each representing multi-billion-dollar annual global market opportunities. The BACKBEAT Global Pivotal Trial evaluating AVIM Therapy has completed enrollment.

AVIM Therapy is a bioelectronic treatment for hypertension, the leading risk factor for death worldwide, and is designed to be delivered by a pacemaker and achieve immediate, substantial and sustained reductions in blood pressure in patients with hypertensive heart disease. The Company has a strategic collaboration with Medtronic (NYSE: MDT), one of the largest medical device companies in the world and the global leader in cardiac pacing therapies, for the development and commercialization of AVIM Therapy for the treatment of uncontrolled hypertension in pacemaker-indicated patients. AVIM Therapy has two FDA Breakthrough Device Designations.

Virtue SAB is a first-of-its-kind, non-coated drug delivery Angioinfusion balloon system designed to infuse a large liquid dose of proprietary extended-release formulation of sirolimus, SirolimusEFR™, for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. Virtue SAB has been granted Breakthrough Device Designation by the FDA for the treatment of coronary in-stent restenosis, coronary small vessel disease and below-the-knee peripheral artery disease. The Virtue Pivotal Trial evaluating Virtue SAB for the treatment of coronary in-stent restenosis is currently enrolling patients.

For further information about Orchestra BioMed, please visit www.orchestrabiomed.com, and follow us on LinkedIn.

Investor Contact:
Silas Newcomb
Orchestra BioMed
[email protected]

Media Contact:
Nina Premutico
Orchestra BioMed
[email protected]
2026-10-22 15:01 3d ago
2026-10-22 05:49 3d ago
Texas Instruments překonal odhady zisku i tržeb
TXN Texas Instruments
FMP Stock News 72
Original source text
Albion Financial Group UT reduced its stake in Texas Instruments Incorporated (NASDAQ:TXN – Free Report) by 19.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,345 shares of the semiconductor company’s stock after selling 5,992 shares during the period. Albion Financial Group UT’s holdings in Texas Instruments were worth $6,819,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in TXN. Strengthening Families & Communities LLC lifted its holdings in Texas Instruments by 3.1% in the third quarter. Strengthening Families & Communities LLC now owns 5,442 shares of the semiconductor company’s stock worth $1,524,000 after acquiring an additional 165 shares during the last quarter. Sowell Financial Services LLC raised its position in shares of Texas Instruments by 7.3% during the 3rd quarter. Sowell Financial Services LLC now owns 4,950 shares of the semiconductor company’s stock worth $1,386,000 after purchasing an additional 338 shares during the period. Atticus Wealth Management LLC lifted its holdings in shares of Texas Instruments by 5.8% in the 3rd quarter. Atticus Wealth Management LLC now owns 1,829 shares of the semiconductor company’s stock worth $512,000 after purchasing an additional 101 shares during the last quarter. Axecap Investments LLC lifted its holdings in shares of Texas Instruments by 1.4% in the 3rd quarter. Axecap Investments LLC now owns 14,954 shares of the semiconductor company’s stock worth $4,188,000 after purchasing an additional 201 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its holdings in shares of Texas Instruments by 5.4% in the 3rd quarter. Quadrant Capital Group LLC now owns 21,056 shares of the semiconductor company’s stock worth $6,061,000 after purchasing an additional 1,078 shares during the last quarter. 84.99% of the stock is owned by hedge funds and other institutional investors.

Texas Instruments News Summary Here are the key news stories impacting Texas Instruments this week:

Positive Sentiment: Strong quarterly beat: Texas Instruments reported third-quarter revenue of approximately $6.06 billion and earnings per share of $2.62, exceeding Wall Street expectations of roughly $5.94 billion and $2.43, respectively. EPS also rose substantially from $1.48 a year earlier. TI reports third quarter 2026 financial results and shareholder returns Positive Sentiment: Broad-based demand growth: Profit reached $2.43 billion, supported by growth across industrial, automotive and data-center markets. The results suggest that recovering analog-chip demand is beginning to benefit Texas Instruments as heavy factory investment starts to moderate. Texas Instruments Posts Higher Profit, Revenue Positive Sentiment: Sales outlook exceeded expectations: Management’s quarterly sales forecast was reported above analyst estimates, providing an additional catalyst after the earnings beat and potentially reinforcing expectations for continued recovery. Analog chipmaker Texas Instruments sees quarterly sales above estimates Positive Sentiment: Shareholder returns remain supportive: Texas Instruments recently raised its quarterly dividend 7% to $1.52 per share, strengthening the stock’s appeal to income-focused investors. Neutral Sentiment: Valuation remains demanding: Despite improving results, TXN trades at more than 40 times trailing earnings, leaving the stock sensitive to any disappointment in future growth, capacity utilization or guidance. Negative Sentiment: Insider selling is a cautionary signal: Recent disclosed activity showed numerous executives selling shares and no reported insider purchases over the past six months. These transactions may reflect compensation or diversification, but they could temper enthusiasm at the current valuation. Insider Activity at Texas Instruments In other Texas Instruments news, VP Tsedeniya Abraham sold 7,000 shares of Texas Instruments stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $264.63, for a total transaction of $1,852,410.00. Following the transaction, the vice president owned 23,181 shares of the company’s stock, valued at $6,134,388.03. The trade was a 23.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.60% of the stock is currently owned by company insiders. Wall Street Analysts Forecast Growth Several brokerages have recently issued reports on TXN. TD Cowen reduced their price target on shares of Texas Instruments from $340.00 to $330.00 and set a “buy” rating for the company in a report on Monday. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Texas Instruments in a report on Tuesday. JPMorgan Chase & Co. increased their price objective on shares of Texas Instruments from $280.00 to $340.00 and gave the stock an “overweight” rating in a report on Thursday, July 23rd. Susquehanna lifted their price objective on shares of Texas Instruments from $300.00 to $340.00 and gave the company a “positive” rating in a research report on Tuesday, July 21st. Finally, Robert W. Baird boosted their target price on shares of Texas Instruments from $300.00 to $385.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Sixteen equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, Texas Instruments currently has a consensus rating of “Hold” and a consensus price target of $302.88.

Get Our Latest Analysis on Texas Instruments

Texas Instruments Trading Up 2.5% Shares of TXN stock opened at $284.65 on Thursday. The stock has a 50-day simple moving average of $271.76 and a 200 day simple moving average of $278.84. Texas Instruments Incorporated has a fifty-two week low of $152.73 and a fifty-two week high of $334.03. The stock has a market capitalization of $259.96 billion, a P/E ratio of 42.28, a P/E/G ratio of 1.55 and a beta of 1.35. The company has a quick ratio of 3.44, a current ratio of 4.86 and a debt-to-equity ratio of 0.72.

Texas Instruments (NASDAQ:TXN – Get Free Report) last released its earnings results on Wednesday, October 21st. The semiconductor company reported $2.62 EPS for the quarter, topping analysts’ consensus estimates of $2.40 by $0.22. The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $5.94 billion. Texas Instruments had a net margin of 31.11% and a return on equity of 35.77%. The business’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.48 EPS. On average, sell-side analysts expect that Texas Instruments Incorporated will post 8.49 earnings per share for the current fiscal year.

Texas Instruments Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 10th. Stockholders of record on Friday, October 30th will be issued a $1.52 dividend. The ex-dividend date is Friday, October 30th. This is an increase from Texas Instruments’s previous quarterly dividend of $1.42. This represents a $6.08 dividend on an annualized basis and a dividend yield of 2.1%. Texas Instruments’s dividend payout ratio is currently 86.45%.

(Free Report)

Texas Instruments Incorporated (NASDAQ:TXN) designs and manufactures analog and embedded semiconductor products used in industrial, automotive, personal electronics, communications equipment, and enterprise systems. Its analog products help manage power, sense and measure real-world signals, and support signal processing, while its embedded processing products provide computing and control functions within electronic systems.

The company offers a broad portfolio of semiconductors, including power-management devices, amplifiers, data converters, microcontrollers, processors, and connectivity products.

Further Reading Five stocks we like better than Texas Instruments GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding TXN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Texas Instruments Incorporated (NASDAQ:TXN – Free Report).

Receive News & Ratings for Texas Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Texas Instruments and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:01 3d ago
2026-10-22 06:26 3d ago
Texas Instruments zvýšil tržby o 27,7 %
TXN Texas Instruments
FMP Stock News 85
Original source text
Diversify Advisory Services LLC increased its position in Texas Instruments Incorporated (NASDAQ:TXN – Free Report) by 122.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,545 shares of the semiconductor company’s stock after purchasing an additional 13,495 shares during the quarter. Diversify Advisory Services LLC’s holdings in Texas Instruments were worth $6,851,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in TXN. Portus Wealth Advisors LLC purchased a new stake in Texas Instruments during the 1st quarter worth $27,000. Scarborough Advisors LLC acquired a new position in Texas Instruments in the 1st quarter worth $29,000. Kilter Group LLC acquired a new position in Texas Instruments in the 2nd quarter worth $31,000. Main Street Group LTD purchased a new position in Texas Instruments in the 1st quarter valued at about $32,000. Finally, Nvwm LLC boosted its position in Texas Instruments by 550.0% in the 3rd quarter. Nvwm LLC now owns 117 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 99 shares during the last quarter. 84.99% of the stock is owned by institutional investors and hedge funds.

Texas Instruments Trading Up 2.5%
TXN opened at $284.65 on Thursday. The stock has a market capitalization of $259.96 billion, a PE ratio of 43.33, a P/E/G ratio of 1.55 and a beta of 1.35. The firm’s fifty day moving average price is $271.76 and its 200 day moving average price is $278.84. The company has a debt-to-equity ratio of 0.72, a current ratio of 4.86 and a quick ratio of 3.44. Texas Instruments Incorporated has a 12-month low of $152.73 and a 12-month high of $334.03.

Texas Instruments (NASDAQ:TXN – Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The semiconductor company reported $2.62 EPS for the quarter, beating analysts’ consensus estimates of $2.40 by $0.22. Texas Instruments had a net margin of 31.11% and a return on equity of 35.77%. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $5.94 billion. During the same period in the prior year, the firm posted $1.48 EPS. The firm’s revenue was up 27.7% compared to the same quarter last year. As a group, research analysts expect that Texas Instruments Incorporated will post 8.49 EPS for the current fiscal year.
Texas Instruments Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 10th. Stockholders of record on Friday, October 30th will be paid a $1.52 dividend. This is a boost from Texas Instruments’s previous quarterly dividend of $1.42. The ex-dividend date is Friday, October 30th. This represents a $6.08 dividend on an annualized basis and a dividend yield of 2.1%. Texas Instruments’s dividend payout ratio (DPR) is currently 86.45%.

Key Stories Impacting Texas Instruments
Here are the key news stories impacting Texas Instruments this week:

Positive Sentiment: Strong quarterly beat: Texas Instruments reported third-quarter revenue of approximately $6.06 billion and earnings per share of $2.62, exceeding Wall Street expectations of roughly $5.94 billion and $2.43, respectively. EPS also rose substantially from $1.48 a year earlier. TI reports third quarter 2026 financial results and shareholder returns
Positive Sentiment: Broad-based demand growth: Profit reached $2.43 billion, supported by growth across industrial, automotive and data-center markets. The results suggest that recovering analog-chip demand is beginning to benefit Texas Instruments as heavy factory investment starts to moderate. Texas Instruments Posts Higher Profit, Revenue
Positive Sentiment: Sales outlook exceeded expectations: Management’s quarterly sales forecast was reported above analyst estimates, providing an additional catalyst after the earnings beat and potentially reinforcing expectations for continued recovery. Analog chipmaker Texas Instruments sees quarterly sales above estimates
Positive Sentiment: Shareholder returns remain supportive: Texas Instruments recently raised its quarterly dividend 7% to $1.52 per share, strengthening the stock’s appeal to income-focused investors.
Neutral Sentiment: Valuation remains demanding: Despite improving results, TXN trades at more than 40 times trailing earnings, leaving the stock sensitive to any disappointment in future growth, capacity utilization or guidance.
Negative Sentiment: Insider selling is a cautionary signal: Recent disclosed activity showed numerous executives selling shares and no reported insider purchases over the past six months. These transactions may reflect compensation or diversification, but they could temper enthusiasm at the current valuation.

Insider Activity
In other news, VP Tsedeniya Abraham sold 7,000 shares of the company’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $264.63, for a total value of $1,852,410.00. Following the sale, the vice president owned 23,181 shares in the company, valued at approximately $6,134,388.03. This represents a 23.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth
TXN has been the subject of several recent analyst reports. Sanford C. Bernstein raised their target price on Texas Instruments from $250.00 to $290.00 and gave the company a “market perform” rating in a research note on Thursday, July 23rd. Evercore reaffirmed an “outperform” rating and set a $330.00 target price (up from $316.00) on shares of Texas Instruments in a research report on Thursday, July 23rd. Rosenblatt Securities boosted their price target on Texas Instruments from $330.00 to $350.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. Robert W. Baird increased their price target on Texas Instruments from $300.00 to $385.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. Finally, JPMorgan Chase & Co. increased their price target on Texas Instruments from $280.00 to $340.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. Sixteen research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $302.88.

Read Our Latest Stock Report on Texas Instruments

Texas Instruments Profile
(Free Report)

Texas Instruments Incorporated (NASDAQ:TXN) designs and manufactures analog and embedded semiconductor products used in industrial, automotive, personal electronics, communications equipment, and enterprise systems. Its analog products help manage power, sense and measure real-world signals, and support signal processing, while its embedded processing products provide computing and control functions within electronic systems.

The company offers a broad portfolio of semiconductors, including power-management devices, amplifiers, data converters, microcontrollers, processors, and connectivity products.

Further Reading

Five stocks we like better than Texas Instruments
GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors

Want to see what other hedge funds are holding TXN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Texas Instruments Incorporated (NASDAQ:TXN – Free Report).

Receive News & Ratings for Texas Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Texas Instruments and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 15:01 3d ago
2026-10-22 09:56 3d ago
Union Pacific překonala odhady zisku i tržeb
UNP Union Pacific
FMP Stock News 88
Original source text
Union Pacific (UNP - Free Report) came out with quarterly earnings of $3.53 per share, beating the Zacks Consensus Estimate of $3.47 per share. This compares to earnings of $3.08 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +1.73%. A quarter ago, it was expected that this railroad would post earnings of $3.2 per share when it actually produced earnings of $3.41, delivering a surprise of +6.56%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Union Pacific, which belongs to the Zacks Transportation - Rail industry, posted revenues of $7.2 billion for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 1.13%. This compares to year-ago revenues of $6.24 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Union Pacific shares have added about 24.5% since the beginning of the year versus the S&P 500's gain of 13.3%.

What's Next for Union Pacific?While Union Pacific has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Union Pacific was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $3.32 on $6.92 billion in revenues for the coming quarter and $13.05 on $26.97 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Transportation - Rail is currently in the top 24% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Canadian Pacific Kansas City (CP - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2026. The results are expected to be released on October 28.

This railroad is expected to post quarterly earnings of $0.95 per share in its upcoming report, which represents a year-over-year change of +18.8%. The consensus EPS estimate for the quarter has been revised 0.5% lower over the last 30 days to the current level.

Canadian Pacific Kansas City's revenues are expected to be $3.02 billion, up 13.6% from the year-ago quarter.
2026-10-22 14:57 3d ago
2026-10-22 06:26 3d ago
Carnegie zvýšila svůj podíl v Accenture o 63,5 %
ACN Accenture
FMP Stock News 78
Original source text
Carnegie Investment Counsel grew its position in Accenture PLC (NYSE:ACN – Free Report) by 63.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 26,565 shares of the information technology services provider’s stock after buying an additional 10,322 shares during the quarter. Carnegie Investment Counsel’s holdings in Accenture were worth $4,871,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Dogwood Wealth Management LLC boosted its position in shares of Accenture by 147.1% during the 2nd quarter. Dogwood Wealth Management LLC now owns 215 shares of the information technology services provider’s stock worth $27,000 after acquiring an additional 128 shares in the last quarter. IMG Wealth Management Inc. increased its stake in Accenture by 134.8% in the first quarter. IMG Wealth Management Inc. now owns 155 shares of the information technology services provider’s stock valued at $31,000 after acquiring an additional 89 shares during the last quarter. Arlington Trust Co LLC raised its position in Accenture by 110.4% during the second quarter. Arlington Trust Co LLC now owns 284 shares of the information technology services provider’s stock valued at $35,000 after purchasing an additional 149 shares in the last quarter. S&G Foundation acquired a new position in Accenture during the second quarter valued at approximately $37,000. Finally, Whipplewood Advisors LLC lifted its stake in Accenture by 57.9% during the first quarter. Whipplewood Advisors LLC now owns 210 shares of the information technology services provider’s stock worth $42,000 after purchasing an additional 77 shares during the last quarter. Institutional investors own 75.14% of the company’s stock.

Accenture Trading Up 0.6% Shares of Accenture stock opened at $240.61 on Thursday. The firm’s 50 day moving average is $192.96 and its 200 day moving average is $175.23. The firm has a market capitalization of $160.68 billion, a PE ratio of 17.74, a price-to-earnings-growth ratio of 1.84 and a beta of 1.11. Accenture PLC has a 1 year low of $118.15 and a 1 year high of $291.09. The company has a current ratio of 1.43, a quick ratio of 1.34 and a debt-to-equity ratio of 0.31.

Accenture (NYSE:ACN – Get Free Report) last issued its quarterly earnings data on Thursday, October 1st. The information technology services provider reported $3.29 EPS for the quarter, beating the consensus estimate of $3.18 by $0.11. Accenture had a net margin of 11.28% and a return on equity of 26.53%. The business had revenue of $18.68 billion during the quarter, compared to the consensus estimate of $18.03 billion. During the same quarter in the prior year, the firm earned $3.03 EPS. The firm’s revenue was up 6.2% compared to the same quarter last year. Accenture has set its FY 2027 guidance at 14.390-14.810 EPS. Equities research analysts forecast that Accenture PLC will post 14.68 earnings per share for the current fiscal year. Accenture Increases Dividend The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 13th will be issued a dividend of $1.71 per share. This represents a $6.84 annualized dividend and a dividend yield of 2.8%. This is a boost from Accenture’s previous quarterly dividend of $1.63. The ex-dividend date is Tuesday, October 13th. Accenture’s dividend payout ratio (DPR) is currently 50.44%.

Wall Street Analysts Forecast Growth A number of brokerages have weighed in on ACN. Argus raised their target price on Accenture from $220.00 to $260.00 and gave the company a “buy” rating in a report on Friday, October 2nd. Jefferies Financial Group set a $220.00 price target on Accenture in a report on Friday, October 2nd. Evercore set a $250.00 price target on Accenture and gave the stock an “outperform” rating in a report on Thursday, October 1st. Deutsche Bank Aktiengesellschaft upped their price objective on Accenture from $136.00 to $175.00 and gave the stock a “hold” rating in a research report on Friday, September 18th. Finally, Morgan Stanley raised their price objective on Accenture from $175.00 to $195.00 and gave the company an “equal weight” rating in a research note on Friday, October 2nd. Ten investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $219.52.

View Our Latest Research Report on ACN

Insiders Place Their Bets In other news, General Counsel Joel Unruch sold 10,498 shares of the stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $162.98, for a total value of $1,710,964.04. Following the completion of the transaction, the general counsel directly owned 17,735 shares in the company, valued at approximately $2,890,450.30. This represents a 37.18% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Catherine Hogan sold 1,320 shares of the firm’s stock in a transaction on Thursday, October 8th. The shares were sold at an average price of $200.00, for a total value of $264,000.00. Following the sale, the chief operating officer directly owned 12,556 shares in the company, valued at approximately $2,511,200. This trade represents a 9.51% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,518 shares of company stock valued at $2,124,932 over the last quarter. 0.02% of the stock is owned by corporate insiders.

Accenture Company Profile (Free Report)

Accenture plc is a global professional services company that helps organizations transform their businesses through consulting, technology and managed services. Its work spans strategy and consulting, technology implementation, operations, and interactive customer experiences.

The company provides services in areas including cloud computing, artificial intelligence, cybersecurity, data and analytics, digital engineering, enterprise software, systems integration and business process outsourcing.

Featured Stories Five stocks we like better than Accenture GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall? Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors Want to see what other hedge funds are holding ACN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accenture PLC (NYSE:ACN – Free Report).

Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-22 14:55 3d ago
2026-10-22 08:45 3d ago
AGNC kryje dividendu 0,36 USD výnosy z portfolia
AGNC AGNC Investment
FMP Stock News 95
Original source text
AGNC Investment (AGNC +1.94%) is coming off a very challenging quarter. The mortgage REIT's earnings and book value both declined during the third quarter, and it posted a negative economic return on tangible common equity. Surging interest rates drove down its share price, sending its dividend yield up to 16.5%. That sky-high yield suggests the payout is on shaky ground.

Despite all that, CEO Peter Federico proclaimed on the third-quarter earnings conference call that "I would say that our dividend continued to be well-aligned with the economics of our business." Here's a look at the conflicting metrics clouding the sustainability of its high-yielding monthly dividend.

Image source: The Motley Fool.

A challenging quarter seems to put its dividend at riskAGNC Investment faced significant pressure during the quarter as surging interest rates weighed heavily on Agency MBS investments. They were the worst-performing fixed-income sector in the Bloomberg U.S. Aggregate Bond Index during the quarter.

The poor performance of Agency MBS drove the mortgage REIT to report a $1.45-per-share decline (16.9%) in its tangible net book value per share, which ended the quarter at $7.13. The mortgage REIT also reported a -12.7% economic return on common equity in the quarter.

Meanwhile, its net spread and dollar roll income per share came in at $0.37. That's dangerously close to the $0.36 per share in dividends it paid during the period ($0.12 each month). It was the third straight quarterly decline in spread income, which was $0.42 per share in the first quarter.

$8.95+$0.17 (+1.94%)

NASDAQ · As of 10:39 AM ET 10/22/26

Why things aren't as bad as they appearFor a typical REIT, the earnings deterioration would be worrisome. However, earnings aren't what drives AGNC Investment's dividend sustainability. CEO Peter Federico discussed the metric that matters more on the call. In response to an analyst's question about his thoughts on the appropriate dividend level in the current environment, he stated, "You've heard me say this before, but the first thing I look at is what is our total cost to capital." He noted that the company "ended the quarter probably somewhere right around 19%-ish as a total cost to capital." He then ran through how this compares to the economics of its business. Federico noted that its existing portfolio generated $0.37 per share of spread income in the third quarter, which was around a 20% return on equity at its lower book value. Meanwhile, he stated that the company can currently generate about a 19% return on equity on new investments, which also aligns with its cost of capital. This drives his view that "our dividend continued to be well-aligned with the economics of our business."

Tight but still alignedChallenging market conditions in the third quarter weighed on AGNC's income and book value. However, it can still generate a high enough return on both its existing portfolio and new investments to cover its cost of capital, including its dividend. That suggests the payout remains safe, at least for now. If its returns start falling below its costs, that would put its dividend at risk. This showcases the risks of investing in AGNC. It currently offers a very high dividend yield due to its high-risk profile. That's the trade-off investors need to be comfortable with before buying the mortgage REIT for income.

Matt DiLallo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2026-10-22 14:54 3d ago
2026-10-22 10:00 3d ago
Akcie společnosti Marathon Digital za měsíc klesly o 41,7 %
MARA.US Marathon Digital Holdings
FMP Stock News 72
Original source text
Marathon Digital Holdings, Inc. (MARA - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Shares of this company have returned -41.7% over the past month versus the Zacks S&P 500 composite's no change. The Zacks Financial - Miscellaneous Services industry, to which Marathon Digital belongs, has lost 6.1% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Marathon Digital is expected to post a loss of $0.04 per share for the current quarter, representing a year-over-year change of +87.5%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

For the current fiscal year, the consensus earnings estimate of -$5.25 points to a change of -42.3% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $1 indicates a change of +81% from what Marathon Digital is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Marathon Digital is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Marathon Digital, the consensus sales estimate of $209.57 million for the current quarter points to a year-over-year change of -17%. The $809.8 million and $1.11 billion estimates for the current and next fiscal years indicate changes of -10.7% and +37.1%, respectively.

Last Reported Results and Surprise HistoryMarathon Digital reported revenues of $174.88 million in the last reported quarter, representing a year-over-year change of -26.7%. EPS of -$0.7 for the same period compares with -$0.81 a year ago.

Compared to the Zacks Consensus Estimate of $208.49 million, the reported revenues represent a surprise of -16.12%. The EPS surprise was -25%.

Over the last four quarters, Marathon Digital surpassed consensus EPS estimates times. The company topped consensus revenue estimates just once over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Marathon Digital is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Marathon Digital. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2026-10-22 14:53 3d ago
2026-10-22 10:11 3d ago
Align Technology zveřejní výsledky za třetí čtvrtletí 28. října
ALGN Align Technology
FMP Stock News 88
Original source text
Key Takeaways Align Technology is set to report Q3 earnings on Oct. 28, with EPS expected to rise 6.1% to $2.77.
Clear Aligner revenues are projected to grow 3.6%, aided by higher volumes and strong international demand.
ALGN's Systems and Services revenues may fall 8% amid capital equipment market challenges and uncertainty.

Align Technology, Inc. (ALGN - Free Report) is set to release third-quarter 2026 results on Oct. 28, after the closing bell.

In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.64, which surpassed the Zacks Consensus Estimate by 3.13%. Align Technology beat on earnings in each of the trailing four quarters, the average surprise being 9.36%.

ALGN’s Q3 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $1.01 billion, which suggests 1.1% growth from the year-ago reported figure.

The Zacks Consensus Estimate for earnings is pinned at $2.77 per share, which implies a 6.1% rise from the year-ago recorded actuals.

Estimate Revision Trend Ahead of ALGN’s Q3 EarningsEstimates for earnings have moved south 1 cent to $2.77 per share in the past 30 days.

Here’s a brief overview of the company’s performance leading up to this announcement.

Factors Shaping ALGN’s Q3 PerformanceClear AlignerThe segment is likely to have benefited from higher Clear Aligner volumes, with particular strength across the EMEA, APAC and Latin America, with continued stability in North America. Both orthodontists and GP dentist channels may have seen volume growth, driven by growth across adults, teens and growing kids. From a product standpoint, it is likely to have seen strong contributions from Invisalign First, the Invisalign Palatal Expander and the Invisalign Mandibular Advancement with Occlusal Blocks (“MOAB”). 

Dental and orthodontic service organizations (DSOs) must have remained a key, scalable growth channel in the to-be-reported quarter, with continued strong progress across all major regions. Meanwhile, the doctor subscription program (DSP), which includes retention, touch-up and relapse cases, is expected to have maintained strong momentum during the quarter. 

The Zacks Consensus Estimate for Clear Aligner revenues indicates 3.6% year-over-year growth.

Labcorp Holdings Inc. Price and EPS SurpriseImaging Systems & CAD/CAM Services (Systems and Services)Within this segment, revenues are likely to have faced a negative impact from continued challenges in the capital equipment market with higher interest rates and increased macro uncertainty. However, in the previous quarter, scanner placements to new doctors reached a record level and increased double digits year over year, driven by continued adoption of iTero Lumina. We expect this trend to have continued in the to-be-reported quarter as well. 

exocad achieved strong revenue growth, reinforcing the company’s strategy to integrate orthodontics and restorative dentistry within a customer and patient-centric digital platform. We expect this trend to have persisted in the third quarter as well. 

The company introduced two new Align Digital Platform capabilities to enhance patient engagement, treatment planning and workflow efficiency. Combined with the Invisalign Palatal Expander platform and customized 3D-printed features, these innovations support a more integrated digital workflow from imaging and diagnosis to treatment delivery. We expect the development to have contributed to the company’s top-line growth. 

The Zacks Consensus Estimate for the segment’s revenues implies a decrease of 8% on a year-over-year basis.

What Our Quantitative Model Predicts for ALGNPer our proven model, stocks with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), along with a positive Earnings ESP, have a higher chance of beating estimates. However, this is not the case here, as you can see below:

Earnings ESP: Align Technology has an Earnings ESP of -2.03%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: The company currently carries a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank stocks here.

Stocks Worth a LookHere are some medical stocks worth considering, as these have the right combination of elements to post an earnings beat this time around:

TG Therapeutics (TGTX - Free Report) has an Earnings ESP of +71.43% and a Zacks Rank #1 at present. The company is expected to release third-quarter 2026 results soon. 

TGTX’s earnings beat estimates in one of the trailing four quarters and missed on the remaining three occasions, the average surprise being 184.65%. The Zacks Consensus Estimate for third-quarter EPS implies a decrease of 84.8% from the year-ago quarter’s figure.

Revvity (RVTY - Free Report) has an Earnings ESP of +1.03% and a Zacks Rank #2 at present. The company is slated to release third-quarter 2026 results on Nov. 3.

RVTY’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 6.59%. The Zacks Consensus Estimate for third-quarter EPS indicates an increase of 9.3% from the year-ago quarter’s figure.

Acadia Healthcare (ACHC - Free Report) has an Earnings ESP of +4.84% and a Zacks Rank #3 at present. The company is slated to release third-quarter results on Nov. 4.

ACHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 47.02%. The Zacks Consensus Estimate for third-quarter EPS calls for a decrease of 36.1% from the year-ago quarter’s figure.
2026-10-22 14:47 3d ago
2026-10-22 09:00 3d ago
Workhorse uzavřel první kanadskou smlouvu s prodejcem
WKHS Workhorse Group
FMP Stock News 88
Original source text
DETROIT, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Workhorse Group, Inc. (NASDAQ: WKHS) (“Workhorse”), an American Industrial Technology company, today announced it has signed a dealer agreement with Tristan Fleet Management inc. (“Tristan”), to sell and service Workhorse vehicles in Canada. Tristan is a leading Canadian fleet management provider offering truck and trailer sales, parts, repair and maintenance, and 24/7 roadside and towing services. This agreement marks the first Canadian dealer partnership for Workhorse, building on years of electric step van deployments in Canada and underscoring the company’s commitment to Canada as a growth region.

Tristan will offer the full line of Workhorse W56 electric step vans, including Standard Wheelbase (178”) and Extended Wheelbase (208”) models with two battery configurations. With cargo capacity up to 34 cubic meters (1,200 cubic feet), payload capacity up to 4,535 kg (10,000 lbs.), and a nominal range of 240 km (150 miles) per charge with the 210 kWh battery, the W56 lineup gives customers flexibility to choose the configuration that best meets their fleet’s operational needs.

“Canadian fleets need proven electric trucks that deliver on quality and performance in any condition,” said James Griffin, Chief Revenue Officer at Workhorse. “The W56 has already proven itself on this front in real-world fleet service across Canada. Tristan’s strong reputation, its extensive network, and ability to provide around-the-clock roadside support will be extremely valuable as Workhorse continues to grow our presence in the country.”

Workhorse has been selling and supporting electric trucks in Canada since 2021 through its partnership with Purolator, a Canadian-owned leading integrated freight, package and logistics solutions provider. Through this experience, Workhorse has deepened critical insights into how to design, engineer, and support electric trucks in some of the harshest operating environments. Workhorse is an approved supplier within the Canoe cooperative purchasing program, which delivers efficient procurement solutions to municipalities, public sector entities, and registered not-for-profit organizations.

“Our customers have been exploring electrification for some time now. With generous incentives from Écocamionnage, as well as the current extremely high cost of fuel, the business case for going electric has never been stronger,” said Daniel Barbu, Tristan’s Vice President and General Manager. “We’re looking forward to helping Workhorse expand its customer base across Canada and supporting our customers meet their own goals for sustainability and vehicle performance.”

Tristan operates seven maintenance locations, five in Québec (Pierrefonds, Saint-Laurent, Saint-Zotique, Boucherville, and Valleyfield) and two in Ontario. In addition to its fleet services, Tristan is an authorized Vanguard trailer dealer and service center in Québec and a dealer for other major brands including Michelin, Cummins, WABCO and MAXON.

Canadian fleet operators interested in the W56 should contact Tristan directly at 514-316-1112 ext. 112 or visit www.tristanfleet.com.

About Workhorse Group Inc.
Headquartered in the Detroit area with a commercial-scale manufacturing plant in Union City, Indiana, Workhorse (Nasdaq: WKHS) is an American Industrial Technology company specializing in electrification, high-voltage systems integration, mobility platforms, ruggedized mobile platform manufacturing, distributed energy systems, and deployable industrial infrastructure. We manufacture durable, reliable and high-performing vehicles and infrastructure for mission-critical applications deployed in the world’s most demanding operating environments. More information is available at www.workhorse.com.

About Tristan
Tristan is a fleet management partner and provider offering truck and trailer sales, parts, repair and maintenance, and 24/7 roadside and towing services. With seven maintenance locations in Québec and Ontario, Tristan is an authorized Vanguard trailer dealer and service center in Québec and a dealer for brands including Michelin, Cummins, WABCO and MAXON. Tristan is a woman-owned business. More information is available at www.tristanfleet.com.

Media Relations Contacts:

Workhorse
John Williams, Communications
+1-206-660-5503, [email protected]

ICR, Inc.
[email protected]

Investor Relations Contact:
[email protected]

Tristan Fleet Management
[email protected]

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of historical fact included in this press release are forward-looking statements. These include statements regarding Workhorse’s dealer relationship with Tristan Fleet Management Inc.; anticipated sales, service and support of Workhorse vehicles in Canada; the W56’s expected qualification for, and the availability and amount of, incentives under Québec’s Écocamionnage program; the expected total cost of ownership and operating savings of the W56 compared with gas-powered vehicles; anticipated fleet operator demand for electric vehicles; and Workhorse’s plans to grow its presence in Canada. Some of these statements may be identified by the use of the words “plans”, “expects” or “does not expect”, “estimated”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, “targets”, “projects”, “contemplates”, “predicts”, “potential”, “continue”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “should”, “might”, “will” or “will be taken”, “occur” or “be achieved”.

Forward-looking statements are based on the opinions and estimates of management of Workhorse as of the date such statements are made, and they are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Some factors that could cause actual results to differ include our ability to raise capital to fund our operations and to maintain access to our current debt facilities; our ability to achieve the expected synergies and/or efficiencies from our operations and as a result of the Motiv/Workhorse merger; our ability to reduce the cost to build our vehicles; our ability to hire and retain the workforce needed; the ability of Tristan Fleet Management Inc. to successfully market, sell and service our vehicles in Canada; our ability to obtain or maintain eligibility for government incentive programs, and the continued availability and terms of such programs; trade policies, tariffs and currency fluctuations affecting cross-border sales; changes in laws, regulations, technologies, the global supply chain, and macro-economic and social environments affecting our business, including demand for electric trucks, fuel prices and our cost of production; and our ability to maintain compliance with Nasdaq rules and otherwise maintain our listing of securities on Nasdaq.

Additional information on these and other factors that may cause actual results and Workhorse’s performance to differ materially is included in Workhorse’s periodic reports filed with the SEC, including Workhorse’s Annual Report on Form 10-K for the year ended December 31, 2025 including those factors described under the heading “Risk Factors” therein, and Workhorse’s subsequent Quarterly Reports on Form 10-Q. Copies of Workhorse’s filings with the SEC are available publicly on the SEC’s website at www.sec.gov or may be obtained by contacting Workhorse. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. These forward-looking statements are made only as of the date hereof, and Workhorse undertakes no obligation to update or revise the forward-looking statements except as required by law.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8022a3ad-132a-4c3b-af42-e8061808e1b2

Workhorse W56 on Cobblestone Street in Montreal, CA A Workhorse W56 step-van parked on a cobblestone street in a Montreal, Canada neighborhood
2026-10-22 14:46 3d ago
2026-10-22 10:01 3d ago
Akcie TJX vzrostly o 10,6 % po silných výsledcích
TJX TJX Companies
FMP Stock News 72
Original source text
TJX (TJX - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this parent of T.J. Maxx, Marshalls and other stores have returned +10.6%, compared to the Zacks S&P 500 composite's no change. During this period, the Zacks Retail - Discount Stores industry, which TJX falls in, has gained 8.4%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

TJX is expected to post earnings of $1.33 per share for the current quarter, representing a year-over-year change of +3.9%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

For the current fiscal year, the consensus earnings estimate of $5.22 points to a change of +10.4% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $5.74 indicates a change of +10% from what TJX is expected to report a year ago. Over the past month, the estimate has remained unchanged.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for TJX.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For TJX, the consensus sales estimate for the current quarter of $15.81 billion indicates a year-over-year change of +4.6%. For the current and next fiscal years, $63.91 billion and $67.82 billion estimates indicate +5.9% and +6.1% changes, respectively.

Last Reported Results and Surprise HistoryTJX reported revenues of $15.18 billion in the last reported quarter, representing a year-over-year change of +5.4%. EPS of $1.22 for the same period compares with $1.1 a year ago.

Compared to the Zacks Consensus Estimate of $15.14 billion, the reported revenues represent a surprise of +0.29%. The EPS surprise was +3.39%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

TJX is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about TJX. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.